Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 17, 2026.

Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis

May A Beydoun, Hind A Beydoun, Alyssa A Gamaldo and 3 more

BMC Public Health · 2014 · Meta-analysis

doi:10.1186/1471-2458-14-643

Abstract

Background. Cognitive impairment, including dementia, is a major health concern with the increasing aging population. Preventive measures to delay cognitive decline are of utmost importance. Alzheimer’s disease (AD) is the most frequent cause of dementia, increasing in prevalence from <1% below the age of 60 years to >40% above 85 years of age.

Methods. We systematically reviewed selected modifiable factors such as education, smoking, alcohol, physical activity, caffeine, antioxidants, homocysteine (Hcy), n-3 fatty acids that were studied in relation to various cognitive health outcomes, including incident AD. We searched MEDLINE for published literature (January 1990 through October 2012), including cross-sectional and cohort studies (sample sizes > 300). Analyses compared study finding consistency across factors, study designs and study-level characteristics. Selecting studies of incident AD, our meta-analysis estimated pooled risk ratios (RR), population attributable risk percent (PAR%) and assessed publication bias.

Results. In total, 247 studies were retrieved for systematic review. Consistency analysis for each risk factor suggested positive findings ranging from ~38.9% for caffeine to ~89% for physical activity. Education also had a significantly higher propensity for “a positive finding” compared to caffeine, smoking and antioxidant-related studies. Meta-analysis of 31 studies with incident AD yielded pooled RR for low education (RR = 1.99; 95% CI: 1.30-3.04), high Hcy (RR = 1.93; 95% CI: 1.50-2.49), and current/ever smoking status (RR = 1.37; 95% CI: 1.23-1.52) while indicating protective effects of higher physical activity and n-3 fatty acids. Estimated PAR% were particularly high for physical activity (PAR% = 31.9; 95% CI: 22.7-41.2) and smoking (PAR%=31.09%; 95% CI: 17.9-44.3). Overall, no significant publication bias was found.

Conclusions. Higher Hcy levels, lower educational attainment, and decreased physical activity were particularly strong predictors of incident AD. Further studies are needed to support other potential modifiable protective factors, such as caffeine.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.

Background

Cognitive function refers to those mental processes that are crucial for the conduct of the activities of daily living. Such mental processes include attention, short-term and long-term memory, reasoning, coordination of movement and planning of tasks. The prevalence of brain disorders affecting cognition (such as stroke and dementia) increases steadily in a linear fashion with age. Cognitive impairment is a major health concern affecting loss of independence in daily activities in old age. Thus, special attention should be devoted to its prevention.

Dementia is relatively frequent in the elderly population and was shown to affect about 6.4% of European subjects over the age of 65 years. A review of 50 original articles published between 1989 and 2002 using international data showed that prevalence of dementia for the very old group (85 years and over) varied from 16.7% in China to 43% in Germany. This variability was also reflected within separate age groups among the very old, ranging from 9.6% to 32% for the 85–89 age category and from 41% to 58% for the 95+ age group. Incidence varied between 47 and 116.6 per 1000 and a separate meta-analytic study estimated the incidence in that age group (i.e. 85+) to be around 104 per 1000.

Alzheimer’s disease (AD) is the most frequent cause of dementia, increasing in prevalence from less than 1% below the age of 60 years to more than 40% above 85 years of age. The initial phase is generally marked by a progressive deterioration of episodic memory. Other impairments may be entirely absent in the beginning or consist of mild disturbances in naming and executive function. When the process advances, impairment spreads to other aspects of memory and other domains of cognition. Despite lack of curative treatment, epidemiological evidence reveals important risk factors for sporadic AD, many of which are non-modifiable (e.g. ApoE ϵ4, age and sex). This highlights the importance for further evaluation of modifiable risk and preventive factors in that these potential factors may not only delay the onset of cognitive decline, but also can be easily treated. Aside from AD, less frequently occurring forms of dementia include vascular dementia (VaD), mixed dementia, dementia with Lewy bodies (DLB) and Parkinson’s disease with dementia (PD-D), diagnostic criteria for which are described in Table 1. The relative prevalence of AD and VaD and the mixed version of both remain debatable. Ott and colleagues estimated that for the very old, the prevalence of AD was 26.8% while that of VaD was 4.4%. However, VaD appears to be more frequent than AD in certain Japanese and Chinese populations.

The present review focuses on selected modifiable risk and protective factors of cognitive impairment, cognitive decline and dementia (including AD), given that they are commonly studied and provide reliable and comparable data. In particular, we focused on the risk and protective factors that could be grouped under three broad categories, namely socioeconomic, behavioral, and nutritional. Consequently, other known risk factors that are modifiable but did not fall under these categories were excluded (e.g. obesity, type 2 diabetes, hypertension, depression, traumatic head injury etc.). In addition, the latter risk factors are potential mediating factors in the causal pathway between our selected factors and cognitive outcomes (e.g. obesity, depression, type 2 diabetes and hypertension may be on the causal pathway between physical activity and cognition; the same for diet→depression, obesity, type 2 diabetes, hypertension→cognition) and thus are more appropriately studied together rather than with their antecedent putative causes. This is the first study to systematically review those selected modifiable risk and protective factors for cognitive health outcomes in cross-sectional and cohort studies while comparing the consistency of association between those factors and across study-level characteristics. It is also among few recent studies to compare the strength of association across those factors in relation to incident AD using a similar approach. Our findings could help guide future research and interventions.

Literature search

Using MEDLINE, we conducted a systematic review of the literature on cognitive function, decline and dementia focusing on specific risk factors. We considered both original research published between January 1990 and October 2012. We did not include titles prior to 1990 to ensure that diagnostic criteria for dementia and AD were comparable across studies. After an initial search using MESH keywords for risk factors (i.e. education, smoking, physical activity, caffeine/coffee/tea, alcohol, antioxidant/vitamin E, homocysteine and fatty acid) and a title containing the words (cognitive, dementia and Alzheimer), we assessed the retrieved papers for relevance by reading the titles and abstracts. Among those that were selected for review, information was retrieved including study design, contextual setting, sample size, main outcome and key findings.

Final inclusion criteria were: (1) Study sample size > 300. Although this number is arbitrary, it was based on the fact that some study outcomes were relatively rare (e.g. incident AD: <10%) and thus a smaller sample size for a cohort study for example might yield an underpowered study, depending on the distribution of the risk factor. (2) Study design is either cross-sectional or cohort study (thus case-control studies, review articles, commentaries, and basic science papers were excluded); (3) Outcomes include dementia, AD, cognitive function, cognitive decline or cognitive impairment (including MCI)). Although all types of dementia were presented in our description of selected studies, focus was on the more prevalent sub-types including AD and VaD (4) Baseline sample includes general healthy population rather than special groups at risk (e.g. coronary heart disease patients). For the “cognitive decline” and “cognitive function” outcomes, we searched risk factors in the title to expand the range of studies selected beyond those based just on MESH keywords (i.e. “caffeine,” “alcohol” and all other risk factors were also searched in titles when the outcome was “cognitive”). Both cohort and cross-sectional studies that were selected are presented in Table 2. The MEDLINE search and the studies excluded are laid out in Figure 1, showing main reasons for exclusion and final number of studies included for each risk factor. After inclusion of a study, we did not examine cross-references in order to ensure the comparability of the search strategy between risk factors.

Out of a total search of 6,837 titles and abstracts between 1990 and 2012 (range:126 for caffeine to 1,692 for education), 247 published original epidemiologic studies (167 cohort-, 80 cross-sectional studies) were included in our review. A database was built accordingly using Endnote ver. X3. Each study was summarized in Table 2 by listing the sample characteristics (age, gender, country), study design, sample size and type of outcome. Given the diversity of types of outcomes, a quantitative meta-analysis for all studies with all outcomes was not possible. Thus, a qualitative method to assess overall consistency was conducted. This analysis was mainly based on the hypothesized direction of association and the final conclusion of the study. Thus, main findings based on the pre-set hypothesis was coded (+: supports the hypothesis; 0: no significant finding; −: against the hypothesis). In addition, within +, we coded studies as partially supporting the hypothesis for three main reasons: “some outcomes but not others”, “some exposures but not others”, “some sub-group(s) but not others”. These papers are sorted by risk factor, year of publication and first author’s last name.

Descriptive analysis

In the descriptive part of the analysis, a data point consisted of a study finding within a design/risk factor dyad (e.g. cohort/education). Using the data points, we conducted an analysis to assess consistency of positive findings across risk factors and study designs (cohort vs. cross-sectional). In particular, we estimated the % of positive findings for all participants and most outcomes; % of positive findings for some outcomes or exposures but not others; % of positive findings for sub-groups; % null findings; % of findings against hypothesized direction. In addition, study-level characteristics (e.g. year and country of publication, study design, type of cognitive outcome, sample size, age group, sex) were described in detail and compared across risk factors, using χ2 test, independent samples t-test and one-way ANOVA.

Consistency analysis: all data points

In this part of the analysis, we modeled study finding as a binary outcome coded as 0=”null finding or finding against hypothesized direction” (referent category), 1=”positive or partially positive finding”, as a function of study-level characteristics using a logistic regression model. The study-level characteristics were entered as main effects as follows: (1) Year of publication; (2) Country of publication (1 = US, 2 = European country, 3 = Others), (3) risk factor (1 = education, 2 = smoking, 3 = alcohol, 4 = physical activity, 5 = caffeine, 6 = antioxidants, 7 = homocysteine, 8 = n-3 fatty acids); (4) sample size (when a range was provided, the average was taken), (5) Study participant age group: 1 = contains ages <65y, 0 = does not contain ages <65y; (6) Participant gender composition: 1 = Men only; 2 = Women only; 3 = Both; (7) Study design: 1 = cross-sectional; 2 = cohort; (8) Number of cognitive outcomes included in the study (e.g. 1 if only incident AD was the outcome; 2 if it is both incident AD and incident dementia); (9) General category of cognitive outcome(s): 1 = dementia/AD/impairment; 2 = cognitive function/decline; 3 = both.

Meta-analysis: data points with incident AD and selected risk or protective factors

Focusing on data points with incident AD as an outcome, we conducted further meta-analysis to assess the strength of the association between selected risk or protective factors and this outcome. This analysis was thus restricted to prospective cohort studies with available data points that had comparable measurements for each risk/protective factor, thus allowing to estimate a pooled measure of association across those data points and studies. The original reported odd ratios (ORs), relative risks (RRs) or Hazard Ratios (HRs) were combined into a pooled value with 95% confidence interval (CI). The RRs were then pooled using random effects models when included study data points were deemed heterogeneous based on the Q-test for homogeneity (p < 0.05) or fixed effect when study data points were homogenous (p > 0.05), which are also presented among results. As such, a summary or pooled RR was provided using forest plots and computed by computing the weighted average of the natural logarithm of each relative measure of interest weighting by the inverse of each RR’s respective variance. Random effects models that further incorporated between-study variability were conducted using DerSimonian and Laird’s methodology.

Considering estimates of exposure prevalence from the largest study with available data on each exposure, we also computed a population attributable risk percentage (PAR%) by pooling data points from all studies together.

As shown in Equations 1.1, 1.2 and 1.3, RR (point estimates per study and data point; 95% CI) was applied to the formula and Prexp was the estimated prevalence of each exposure. The estimation of SE for PAR% was obtained using the delta method.

Finally, in order to examine publication bias, we used Begg’s funnel plots; each RR point estimate was plotted against their corresponding standard errors (SE) for each study on a logarithmic scale, for all exposures combined. This type of bias was also formally tested using the Begg-adjusted rank correlation tests and the Egger’s regression asymmetry test. All analyses were conducted with STATA 11.0 (StataCorp, College Station, TX). Type I error was set at 0.05 for all measures of association.

Socio-economic Status (SES) as indicated by education

Early life conditions are related to cognitive development and abilities in childhood and cognitive function in adulthood. Low educational attainment and other markers of low socio-economic position (SEP) were associated with poorer cognitive function in adulthood and age-related cognitive decline and impairment, as well as greater risk or prevalence of dementia and AD in the elderly. In this study, we focused our attention on education as a maker of SES, given that it is the most commonly studied protective factor.

Several possible mechanisms support the finding that less education is related to cognitive decline: First, education may exert direct effects on brain structure early in life by increasing synapse number or vascularization and creating cognitive reserve. This was named the “reserve capacity” hypothesis. Thus, this hypothesis states that early life conditions affect the pace of cognitive decline in later life. Education in early life may have effects in later life if persons with more education continue searching for mental stimulation (“the use it or lose it” hypothesis), which may lead to beneficial neurochemical or structural alterations in the brain. Indeed, in one study, recent mental stimulation was associated with improved cognitive functioning. Alternatively, education may act through several “behavioral mediators” to improve health in general, and cognitive functioning in particular. This hypothesis was confirmed by a study using the Framingham cohort which suggested that education was uniquely protective against VaD and not associated with AD. This finding was explained by mediating effects of other risk factors of cognitive decline, including smoking and hypertension, which in turn can initiate cerebrovascular damage. However, Lee and colleagues found evidence contrary to this hypothesis by showing a sustained strong association between education and cognitive functioning after adjustment for behavioral and health-related factors.

Based on our findings (Table 2 and Figure 2A), 18 (66.7%) of the 27 cohort studies that met our selection criteria found that lower education was linked to a worse cognitive outcome in the overall population and for all studied outcomes, 1 found this relationship with incident VaD but not AD, 1 found the relationship with cognitive function but not decline, 1 concluded that IQ was a better predictor than education, and 2 detected a significant association in the hypothesized direction only in women and in ApoE4- individuals. The remaining four cohort studies did not find an association in the hypothesized direction.

Note: +(ALL) = positive finding, given hypothesis, for all subjects and most outcomes of interest; +(some outcomes) = positive finding, given hypothesis, for all subjects and some outcomes of interest but not others; +(some groups) = positive finding, given hypothesis, for some groups and most outcomes of interest; 0 = null finding, given hypothesis; − = finding against hypothesized direction. *P-value based on χ2 test for independence between risk factor and finding.

The association between education and the studied cognitive outcomes was in the hypothesized direction, with higher education being protective, for the majority of the selected cross-sectional studies (21 out of 25, 84%), while 2 found an association with prevalent AD but not VaD, 1 found that literacy was a better predictor than education, and 1 failed to detect a significant association (See Table 2 and Figure 2B).

Behavioral factors

Several behavioral factors were selected, including smoking, alcohol drinking,and physical activity.

Smoking

Smoking is a risk factor for several chronic diseases, but its long-term relationship with dementia of various sub-types is still controversial. In fact, smoking is well known to increase the risk of stroke and thus subsequent vascular types of dementia (VaD). However, many studies have concluded that smoking status influenced risk of VaD independently of stroke status and thus may have an effect beyond cerebrovascular disease. In addition, studies that have shown a direct impact of smoking on AD, suggest that smoking might in fact influence neurodegeneration. A vast amount of literature points to a role of smoking in oxidative stress and inflammation, both mechanisms believed to play a key role in AD.

However, it is also biologically plausible that smoking might protect against cognitive decline and AD, given that nicotine, a key active component of tobacco, may enhance the release of acetylcholine, increase the density of nicotnic receptors, therefore improving attention and information processing. It is now known that AD is characterized by cholinergic system deficits which may be delayed through tobacco consumption.

Population-based evidence of an effect of smoking on cognitive outcomes was inconclusive, with most longitudinal studies reporting weak or null associations. However, a number of other cohort studies have found a positive association between smoking and risk of incident dementia and AD as well as incident cognitive impairment and age-related cognitive decline.

For instance, the British 1946 birth cohort study pointed to the difficulty of finding an association between smoking and cognitive impairment given the differential high mortality of smokers especially among the elderly population. After controlling for a range of socioeconomic and health status indicators (both physical and mental), they found that smokers who survive into later life may be at risk of clinically significant cognitive decline. However, these effects were accounted for largely by heavy smokers, i.e. those who smoked 20 cigarettes per day or more. Earlier research on middle aged adults suggested that current smoking and number of pack-years of smoking were related to reduced performance on tests of psychomotor speed and cognitive flexibility assessed approximately five years later. Similar results were shown for cognitive decline in a large cohort study (Rotterdam study) conducted in multiple European countries and in another more recent study conducted in the United States.

Among studies that examined incidence of AD in relation to smoking status, two of the largest European cohort studies reported conflicting results. While one found no relationship between smoking status and incident AD among a large sample of 34,439 older UK men (mean age: 81), the recent 2011 study found that heavy smoking increased the risk of dementia and AD in a younger sample of 21,123 older Finnish adults (Mean age:60.1) that comprised both men and women.

In sum, 16 (55.2%) out of the 29 selected cohort studies linking smoking to the various cognitive outcomes found the relationship to be in the hypothesized direction in the entire population that was studied and for most outcomes of interest, while 2 found this relationship for some outcomes but not others and 2 detected it for a sub-group of the total population, while the remaining 9 studies did not find an association or found an association in the opposite direction. (See Table 2 and Figure 2A).

Only 2 (28.6%) of the 7 cross-sectional studies found an association in the hypothesized direction, while 2 detected it for a sub-group of the total population, and the remaining 3 did not detect a significant association, (See Table 2 and Figure 2B).

Alcohol

Alcohol consumption in moderation was hypothesized to be protective against cognitive decline and impairment in old age. Several mechanisms may be involved in explaining the potential protective effect of moderate alcohol consumption on various cognitive outcomes. First, this effect might be mediated through cardiovascular risk factor reduction, partly through a dampening effect of ethanol on platelet aggregation, or through a modification of the serum lipid profile. Second, another potential mechanism in which alcohol can have a direct effect on cognitive function is through acetylcholine release in the hippocampus, which in turn enhances learning and memory.

The Rotterdam study also examined the effect of alcohol use on cognition. They found that past alcohol consumption’s effect on speed and flexibility appeared to be slightly U-shaped, with the best performance observed among those who drank 1–4 glasses of alcohol per day, although this association was stronger among women than among men. Other studies also detected sex differences. Light to moderate alcohol consumption was also found beneficial based on findings of other cohort and cross-sectional studies with a U- or J-shaped pattern observed. However, in other studies, a linear dose–response relationship between alcohol use and improved cognition was noted, though the authors cautioned that these should not encourage increased alcohol consumption without an upper bound to this consumption.

In one cross-sectional study, a linear relationship between alcohol consumption and cognitive function was found in women but a U-shaped pattern was found in men. One cohort study found that overall, moderate consumption was protective against poor cognitive function, but had an opposite relationship with cognitive function among ApoE4+ individuals, while another found that alcohol use in general was related to better cognition without effect modification by ApoE4 status. Slower memory decline with increased alcohol consumption in men was found in one study, though the opposite relationship was found in the case of psychomotor speed among women. The positive association between alcohol intake and memory was also noted in at least one other cross-sectional study for both men and women combined. Moreover, heavy alcohol use was linked to poorer cognitive outcomes in a few studies. Finally, only a few studies among those that were selected found no associations between alcohol consumption and cognitive outcomes.

In fact, 8 out of the 18 selected cohort studies (44%) linking alcohol consumption to the various cognitive outcomes, found the relationship to be in the hypothesized direction (but were U-shaped, J-shaped or linear) in the entire population that was studied and for most outcomes of interest, while 2 found this relationship for some outcomes but not others and 4 detected it for a sub-group of the total population. Moreover, 1 cohort studies have indicated that alcohol use was generally linked to poor cognitive outcomes for the total population. Finally, 3 did not find any significant associations between alcohol consumption and the various cognitive outcomes that were under study. (See Table 2 and Figure 2A).

9 of the 12 cross-sectional studies (75%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest. The remaining 3 studies either found this U-shaped or J-shaped association in a sub-group, and either failed to detect any association or detected one that was not in line with the hypothesis, whereby alcohol use was generally found to result in poor cognitive outcomes. (See Table 2 and Figure 2B).

Physical activity

Physical activity has many well-known benefits for preventing a number of chronic disorders, including coronary heart disease, stroke, diabetes mellitus and osteoporosis. However, its impact on cognitive functioning has not been studied extensively. Several mechanisms may underlie the potentially protective effects of physical activity on cognitive function, including sustained cerebral blood flow, improved aerobic capacity and cerebral nutrient supply as well as growth factors, specifically the brain-derived neurotropic factor, which is a molecule that increases neuronal survival, enhances learning, and protects against cognitive decline.

Currently, 24 cohort and 4 cross-sectional studies have examined the hypothesized relationship. For instance, a recent cohort study of 716 dementia-free older adults from the Rush Memory and Aging Project who were followed-up for an average of 4 years found an inverse relationship between total daily physical activity and incident AD after controlling for age, sex, education, self-report physical, social, and cognitive activities, as well as current level of motor function, depressive symptoms, chronic health conditions, and ApoE4 allele status. Furthermore, a recent cross-sectional study of 9344 women, 65 years and older, found a lower prevalence of cognitive impairment among those who reported being physically active versus those who reported being physically inactive at different stages of their lives.

These findings suggested that physical activity could represent an important and potent protective factor for cognitive decline and dementia in elderly persons. Significant findings were obtained by other recent cohort and cross-sectional studies. Only one cohort study resulted in non-significant findings.

In sum, of the 24 selected cohort studies linking physical activity to the various cognitive outcomes, 21(87.5%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest, while 1 found this relationship in ApoE4 carriers and 1 in non-carriers. In one cohort study, the association was against its hypothesized direction. (See Table 2 and Figure 2A).

In addition, all 4 of the selected cross-sectional studies (100%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest (See Table 2 and Figure 2B).

Nutritional factors

Nutritional factors being studied in relation to cognitive outcomes included caffeine consumpion, antioxidant nutrients and Hcy. In addition, special attention was devoted recently to one class of essential fatty acids, namely n-3 fatty acids.

Caffeine

Caffeine is known to be the most widely used psychoactive drug worldwide. Its main source is coffee particularly in Western diets. Acting as a stimulant of the central nervous system, caffeine causes heightened alertness and arousal. Previous literature yielded inconsistent findings about the effects of caffeine consumption on cognitive processes. In fact, caffeine improved perceptual speed and vigilance, as well as more complex functions such as memory. Caffeine is one type of compound known as methylxanthines whose effects are mainly to block adenosine receptors in the brain, resulting in cholinergic stimulation. It was hypothesized that such stimulation would lead to improved memory. The earliest large cross-sectional study conducted by Jarvis and colleagues found that caffeine improved cognitive performance. Later on, other cross-sectional studies focusing on tea consumption found similar results. Others, however, did not show evidence of a significant protective effect. In sum, 4 of 7 selected cross-sectional studies linking caffeine consumption to various cognitive outcomes found the relationship to be in the hypothesized direction in the study population and for most outcomes of interest (57.1%), one found this association in men and two failed to find a significant association. (See Table 2 and Figure 2B).

Of 11 cohort studies, positive findings pertained to 3 (27.3%), though this was found only for coffee intake in two studies, while 5 recent studies detected this association only among women or for specific exposures. The remaining cohort studies (3 of 11, 27%) did not find an association between caffeine intake and cognitive change or incident dementia. Given the paucity of large cohort studies, more research is needed to establish causality (See Table 2 and Figure 2A).

Antioxidants: focus on vitamin E

Several findings suggest that oxidative stress may play an important role in the pathogenesis of AD. First, the brains of AD patients have lesions that are associated with exposure to free radicals. Moreover, oxidative stress among these patients is also marked by an increased level of antioxidants in the brain that act as free radical scavengers. Finally, in vitro studies suggest that exogenous antioxidants may reduce the toxicity of β-amyloids in the brains of AD patients. Based on these findings, it may be hypothesized that dietary antioxidants may help reduce the risk of AD.

Those epidemiologic studies examined the longitudinal relationship between supplemental antioxidants and risk of AD and other dementias found conflicting results: While vitamin C supplement use was related to lower AD risk in one cohort study, combined supplementation of vitamin E and vitamin C was associated with reduced prevalence and incidence of AD and cognitive decline in three other cohort studies, whereas another study found this effect to be specific to Vitamin E supplements. These findings of a protective effect of supplemental antioxidant use against cognitive impairment and decline was replicated in a large cohort study. However, there were only borderline or little evidence of a cognitive benefit from use of antioxidant supplements, particularly vitamins C and E, according to at least five independent cohort studies.

There are several prospective cohort studies on the effect of dietary antioxidants on the risk of dementia. One study found that high dietary intake of vitamins C and E may reduce the risk of AD with the relationship most pronounced among smokers. Morris and colleagues found that dietary intake of vitamin E, but not other antioxidants, was associated with a reduced risk of incident AD, although this association was restricted to individuals without the Apolipoprotein E ϵ4 genotype. Similar findings were reported with cognitive decline as an outcome. In a later study when both outcomes were considered it was concluded that certain forms of tocopherols not found in dietary supplements but found only in foods may be at play. This observation was corroborated by at least one recent study. Another study, however, suggested that dietary antioxidants were not able to reduce AD risk. Similarly, Laurin and colleagues found no association between midlife dietary intake of vitamins E and C and dementia incidence. At least five other cohort studies came to a similar conclusion. In addition to examining associations of cognition with vitamins C and E, other studies found that carotenoids, particularly β-carotene intake, may be have beneficial effects of various cognitive outcomes, though others were not able to detect such an association.

Irrespective of the source of antioxidants, plasma concentration may be a good biomarker for oxidative stress status. In particular, an inverse association between plasma vitamin E among others and poor cognitive outcomes was found in at least two cross-sectional studies and two cohort studies. Another cross-sectional study, however, did not find evidence of an association between plasma antioxidants, including vitamin E and prevalent AD. In addition, among studies that examined the influence of plasma carotenoids, only one detected a significant potential protective effect against cognitive impairment. While these results are mixed, they suggest that at least one antioxidant has a protective effect against adverse cognitive outcomes.

In sum, of the 21 selected cohort studies linking antioxidants, with focus on vitamin E, to the various cognitive outcomes, 9 (42.9%) found the relationship to be in the hypothesized direction in the entire population that was studied and for most outcomes of interest, while 5 found this relationship for specific antioxidants or some outcomes but not others and 1 detected it for a sub-group of the total population. The remaining selected cohort studies (n = 6) did not find a significant association. (See Table 2 and Figure 2A).

Similarly, of the 6 cross-sectional studies that were selected, 2 (33.3%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest, 1 found the association to hold only for vitamin E, whereas 3 found no significant association. (See Table 2 and Figure 2B).

Homocysteine

An elevated level of plasma concentration of the sulfur amino acid Hcy (hyperhomocysteinemia) is recognized as an independent risk factor for cardiovascular, peripheral vascular, and cerebrovascular disease. Accordingly, a potential influence of hyperhomocysteinemia on cognitive functioning among older adults was postulated and several studies were able to associate high levels of Hcy with increased risk of incident AD or all-cause dementia. Studies have pointed to selective effect of Hcy on specific domains of cognition. One explanation could be that Hcy might be affecting certain parts of the brain to a greater extent than others, and studies have linked Hcy to higher degree of white matter hyperintensities and with brain atrophy.

Even though blood Hcy levels increase with age and diminished renal function, it is largely determined by dietary intake of B-vitamins (mainly B-6 and B-12) and folate which are needed to convert Hcy into methionine and cysteine, through the methylation reactions. Thus, Hcy status in plasma can be modified by dietary interventions. Moreover, vitamin B-12 plasma level has been shown to be inversely related to that of Hcy and studies looking at Hcy levels and cognitive functioning also examined the effect of B-vitamins. In particular, vitamin B-12 was found to be protective against decline in at least three recent studies. At least five other studies concluded that fotate was protective against cognitive impairment or decline. For Vitamin B-6, two other studies suggested a protective effect. An antagonistic interaction of folate and Vitamin B-12 with Hcy’s effect on cognition was noted in other studies. Aside from its link to cardiovascular disease, Hcy was shown to have neurotoxic and excitotoxic properties in vitro, suggesting a direct influence on cognition.

Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest, while 2 found this relationship for some outcomes but not others or a sub-group and 5 were not able to detect a significant association. (See Table 2 and Figure 2A).

Similarly, of the 14 cross-sectional studies that were selected, 11(78%) found an association in the hypothesized direction for the entire study population and for most outcomes of interest, 1 found an association only among older adults above age 60y, 1 detected it among ApoE4+ individuals, and 1 found no significant relationship. (See Table 2 and Figure 2B).

n-3 fatty acids

Another nutritional factor hypothesized to be protective against cognitive decline is higher intake of n-3 fatty acids and/or a better balance of n-3/n-6 fatty acids. Linoleic(LA ~ 18:2n-6) and α-linolenic (LNA ~ 18:3n-3) are two types of fatty acids that are essential for all members of the animal kingdom. These fatty acids and their respective derivatives are also commonly referred to as n-6 and n-3 fatty acids. Their essentiality lies in the fact that they cannot be synthesized de novo within the human or animal organism.

In the past, n-3 fatty acids were classified only as essential because of their ability to alleviate deficiency symptoms that include dermatitis, growth retardation and reproductive failure. However, n-3 fatty acids have other important neurological functions, which explain their high concentrations in neural and retinal tissues. Some of the longer chain fatty acids that are synthesized from α-linolenic acid include Eicosapentanoic acid (EPA ~ 20:5 n-3), which through further elongation, desaturation and β-oxidation produces Docosahexaenoic acid (DHA ~ 22:6 n-3). On the other hand, products of linoleic acid which are also termed long-chain n-6 fatty acids include gamma-linoleic (GLA ~ 18:3 n-6), dihomogammalinolenic acid (DGLA ~ 20:3 n-6) and Arachidonic acid (AA ~ 20:4 n-6). Of all organs in the human body (excluding adipose tissue), the nervous system has the highest lipid content. The dry weight of an adult brain is 50% to 60% lipid, and 35% of the lipid content is accounted for by polyunsaturated fatty acids (PUFAs).

A review of scientific articles and biochemistry textbooks suggested that the fatty acid composition of neuronal cell membrane phospholipids reflects their intake in the diet. Fish oils, which contain high levels of C20 and C22 PUFA, exert the most profound influence on brain PUFA concentrations. The ratio between n-3 and n-6 PUFA may influence various aspects of serotoninergic and catecholaminergic neurotransmission, and it has been shown that by increasing the density of neurotransmitter receptors for acetylcholine and dopamine, dietary n-3 PUFA can improve learning and memory processes.

Previous observational studies suggested that the biochemical composition of blood components in terms of fatty acids differs significantly between subjects with normal cognitive functioning and patients with some form of cognitive impairment. While the majority of these studies showed an inverse association of plasma and erythrocyte n-3 fatty acids with cognition among older adults, at least one found no association between biochemical markers of n-3 fatty acids and cognition.

Epidemiological studies involving self-reported dietary data of n-3 fatty acids had suggestive but slightly controversial results. One study by Morris and colleagues used cohort data on 815 subjects who were initially unaffected by AD (age range: 65-94y, mean follow-up period = 2.3y). Using standardized criteria, AD incidence was compared across n-3 fatty acid consumption groups, with those eating fish once per week compared to those who rarely or never eat fish having considerably lower incidence (RR = 0.4; 95% CI: 0.2, 0.9). Total n-3 fatty acid consumption was also associated with a reduced AD risk even after controlling for intake of other dietary fats, vitamin E and for cardiovascular conditions. A similar finding was reported later on for a larger but comparable cohort when looking at fish consumption and cognitive decline over time.

In the Zutphen Elderly Study, cognitive functioning and decline over three years were assessed in a cohort of 476 men aged 69-89y using the Mini-Mental State Examination (MMSE). Findings indicated that high linoleic acid intake (the main n-6 fatty acid in the diet) was associated with cognitive impairment, even after controlling for age, education, cigarette smoking, alcohol consumption and energy intake (OR = 1.76, 95% CI: 1.04-3.01, comparing highest to lowest tertile). However, there was no distinctive association for n-3 fatty acids. Nevertheless, total fish consumption was suggestive of a protective effect, even though it did not reach significance.

Another larger cohort study–The Rotterdam Study– recruited 5,386 non-institutionalized participants, aged 55 + y at baseline, who had normal cognition and assessed their complete dietary intake with a semi-quantitative food-frequency questionnaire. After an average 2.1y of follow-up, lower risk of incident dementia and AD was found among fish consumers and therefore among those with higher intake of n-3 fatty acids (RR = 0.3; 95% CI: 0.1-0.9). However, when the study was conducted later with a longer follow-up (mean follow-up period of 6.0 years), it was concluded that high intake of total, saturated, trans fat, cholesterol and low intake of monounsatured fatty acids (MUFA), total PUFA, n-6 PUFA and n-3 PUFA were not associated with increased risk of dementia or its subtypes.

A cross-sectional study of 1,613 subjects aged 45–70 years that examined the association between fatty acid and fish intake with cognitive function, found that the risk of cognitive impairment was reduced with increased consumption of fatty fish and marine n-3 PUFA. per Standard Deviation (SD) increased intake, the ORs were 0.81 (95% CI: 0.66, 1.00) and 0.72 (95% CI: 0.57, 0.90), respectively. Another recent study using the Athersclerosis Risk in Communities (ARIC) cohort data suggested that dietary intake of n-3 fatty acids (mainly DHA + EPA) reduced the risk of cognitive decline in verbal fluency but not other cognitive domains (i.e. delayed word recall and psychomotor speed). This protective effect was particularly strong among hypertensive subjects. The potentially protective effect of dietary n-3 fatty acid was also reported in several other large epidemiological studies, but not in others.

In sum, 7 out of the 18 (39%) selected cohort studies linking n-3 fatty acids to the various cognitive outcomes found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest, while 1 found this relationship for some outcomes but not others, 4 detected it for a sub-group of the total population, and 6 found no association (See Table 2 and Figure 2A). In addition, all of the 5 (100%) cross-sectional studies that were selected found an association in the hypothesized direction for the entire study population and for most outcomes of interest (See Table 2 and Figure 2B).

Description of study-level characteristics and comparison by risk factor

Table 3 shows descriptive findings of study-level characteristics and compares their distributions across risk factors. Out of the 247 selected studies, 98 were conducted in the US (39.7%), while 104 were carried out in a European country (42.1%), and the remaining 45 studies originated from Asia, Canada and Australia among others (18.2%). The majority of the selected studies were cohort studies (n = 167). Most had only one type of cognitive outcome (72.5%), whereas 24.3% had two, and the remaining 3.2% had 3 or 4 outcomes. 152 studies had confirmed positive findings for most outcomes, exposures and for all study sub-groups (61.5%), while 18.2% (n = 45) had null findings. Partially positive findings were found in around 18.2% while 2% had a finding against the hypothesized direction. Around 40.5% of studies included participants with ages <65y, and the majority had both men and women (84.2%). Incident AD as an outcome was available in 47 studies, while 47 studies included incident dementia as a main outcome of interest. On the other hand, cognitive function as an outcome was found in 83 of included studies, while 62 of those studies had cognitive decline or change as a primary outcome of interest (data not shown). In general, there was an almost even split between studies focusing on cognitive function/decline/change (51.0%) and studies focused on AD/dementia/impairment as outcomes (46.2%). Only 2.8% of the studies examined both categories. When comparing the distribution of those study-level characteristics by risk factor, we found some significant differences for year of publication, country, age group inclusion/exclusion, study design, cognitive outcome type and study finding. In particular, studies on education and cognitive outcomes tended to be published earlier than studies of other risk factors, there were significantly more European studies of n-3 FA compared to other risk factors, while most studies with PA excluded middle aged adults unlike other risk factors. The highest proportion of cohort studies was also found for PA. The vast majority of studies on alcohol and cognitive outcomes used cognitive function/decline as their primary outcome of interest, unlike other risk factors which were more balanced in terms of cognitive outcome type. The percent positive finding was highest among PA studies (89.3%) and lowest for caffeine studies (38.9%). The significant difference in percent “positive finding” was found in cohort studies (p = 0.043) rather than cross-sectional studies (p = 0.09) (See Figure 2A-B).

Consistency analysis: study-level characteristics and risk factor as predictors of study finding

In an attempt to examine heterogeneity in findings across risk factors and study-level characteristics, we conducted a consistency analysis using a logistic regression model (Table 4). Examining the odds ratios and their 95% CI, taking “null finding/against hypothesis finding” as the referent category for the outcome, we found that in general, a positive or partially positive finding was significantly more likely when the risk factor was “education” particularly when compared to smoking, caffeine and antioxidants/vitamin E (p < 0.05). None of the other study-level characteristics were associated with the study finding.

Meta-analysis: selected risk factors for incident AD

Using random effects models, we pooled findings of 31 selected data points from 31 studies in which the outcome was incident AD and for which exposure data was adequate and comparable across studies (Figure 3A-E). Among studies used to summarize the association between low education and incident AD, the largest study (N = 3,675) found a HR = 1.81 with 95% CI: 1.30–2.53, with a prevalence of low education being ~32%. In all four studies, the exposure definition was standardized as a comparison between <8y of education vs. ≥8y. In contrast, for all other exposures, definitions differed to some extent between studies but were assumed to operationalize the same concept. For instance, high vs. low physical activity was defined as a frequency of 3 times or more per week by two studies, 2 times of more per week by one, 4 activities per week by one, ≥2 vs. <2 mile walk/day by another study, and other comparable definitions by the remaining four studies combining frequency and intensity of activity. A full description of how various exposures were defined under Figure 3A-E notes.

Sources:: Notes: Only studies with available data points on incident AD were selected. Moreover, risk factors/protective factors needed to be measured in a comparable manner across studies to allow for estimating a pooled RR with a 95% CI. For education, only four studies out of 27 cohort studies had the required inclusion criteria. For smoking status, the common referent category was non-smoking or never smoking or « never or former » whereas exposed group consisted of either « ever smokers », or a pooled value for RR to obtain an approximate « ever smoker » category, or current smokers, or mid-life smoking or heavy smoking. For high vs. low physical activity level, two studies used the cut-point of 3 or more times per week, one used 2 times or more per week, one used the criterion of 4 activities per week vs. none, one used > =2 vs. <2 miles walking/day, and the remaining four studies used other definitions related to both frequency and intensity. For high vs. low n-3 fatty acids, one study had fish consumption (yes vs. no) as the exposure of interest, another examined quintiles of total n-3 PUFA and compared the fifth to the first quintile in terms of risk for AD, a third study had one main exposure as « weekly consumption of fish vs. not », a fourth study contrast high vs. no fish intake, 0-8y follow-up, and finally upper quartile vs. lowest quartile for total n-3 PUFA in erythrocyte membranes. For high vs. low Hcy, two studies used a cut-point of 14.6 μmol/L, one study used a cut-point of 15 μmol/L, one study used upper vs. lowest quartile and one study used upper tertile vs. lowest tertile.

Tests of heterogeneity, including the Q-tests, determined whether to use fixed-effects or random-effects models to pool the RR. Findings indicated that, with the exception of education and smoking as main exposures, RR estimates obtained from individual studies were largely homogenous. In sum, the pooled RRs were: 1.99 (1.30, 3.04) for low vs. higher educational attainment (n = 4 data points; Q = 11.33, p = 0.010); 1.37(1.23-1.52) for smoking status (current or ever vs. never smokers (n = 9 data points, Q = 36.2, p < 0.001); 0.58(0.49, 0.70) for physical activity (n = 8 data points, Q = 3.2, p = 0.867), 0.67(0.47,0.96) for high intake of n-3 fatty acids (n = 5, Q = 7.4, p = 0.116), and RR = 1.93(1.50, 2.49) for high levels of plasma Hcy (n = 5 data points; Q = 2.64, p = 0.620).

Taking the largest study for each as a means to obtain an estimate of exposure prevalence, the following was found: low education (32%), mid-life smoking (59.8%), lower physical activity (62%), lower n-3 fatty acids (49.4%), elevated Hcy (30%). From these exposure prevalence estimates (Prevexp), we computed the PAR% and its 95% CI to assess the proportion of AD that is attributable to each exposure in a typical adult population and thus the % that can be averted if that exposure was eliminated from that population. Our findings indicated that the PAR% for low education was 24.0% with a 95% CI: 8.4-39.6; for mid-life smoking it was 31.0% with a 95% CI: 17.9-44.3; for physical activity (lower vs. higher) it was 31.9% with 95% CI: 22.7-41.2; for high vs. low Hcy, it was 21.7% with a 95% CI: 12.8-30.6; for lower vs. higher fish consumption (<weekly vs. ≥weekly), it was 21.9% with 95% CI:4.7-39.1.

Publication bias for the meta-analysis data points (n = 31) was assessed using primarily the funnel plot which plotted point estimates of RR for all exposures combined on the Loge scale against their standard errors. This plot indicated that estimates obtained from those 31 studies lay within the pseudo 95% confidence limits, an indication of non-appreciable publication bias. This finding was reinforced by a non-significant Begg-adjusted rank correlation test (Z = 0.25; P = 0.80), and by Egger’s regression asymmetry test (bias (SE): -0.43 (0.98); p = 0.66) (Additional file 1: Figure S1).

Discussion

As stated earlier, this is the first study to systematically review those selected modifiable risk and protective factors for cognitive health outcomes in cross-sectional and cohort studies while comparing the consistency of association between those factors and across study-level characteristics. It is also among few recent studies to compare the strength of association across those factors in relation to incident AD using a similar approach. However, our study has a few limitations. First, the literature search was limited to published articles in English available in the Medline database. Second, comparing all included studies in a quantitative meta-analytic manner was not possible due to the diversity of the cognitive outcome measurements between original studies included. In fact, cognitive measures included scores from batteries of different cognitive tests, single global cognitive test scores such as the MMSE total score, as well as the use of a factor analytic approach to combine test scores into various domains of interest (e.g. memory, spatial, psychomotor, executive function, attention). Thus, meta-analysis was only possible for measures of cognitive impairment (i.e. MCI, all-cause dementia, AD, VaD) from which we selected incident AD as the most comparable outcome across studies. However, in order to measure consistency across the selected studies and compare risk factors in terms of consistency, we conducted another type of analysis in which a qualitative outcome of “study finding” was modeled against study-level characteristics. The qualification of a finding as null or positive was based on the main conclusion of each study that was included. This type of analysis does not necessarily discriminate between null findings due to low power, poor quality study vs. actual null finding. However, our logistic regression analysis indicated that overall, sample size was not a determining factor for the study finding outcome. Combining findings from meta-analysis and the consistency analyses, we compared evidence level for each risk and protective factor of cognitive health. Other limitations include the lack of comparability in measurements of risk or protective factors in studies with incident AD, which resulted in the exclusion of a few data points in our meta-analysis. However, the datapoints that were included in the meta-analysis were relatively comparable as described in the footnotes of Figure 3A-E. Finally, our study was limited by the inability to create a common quality measure for all studies given the diversity of the exposure variables and the relative importance of having a large sample size given the type of exposure (e.g., a larger sample size is needed for a questionnaire-based exposure vs. a blood level based exposure).

Our review shows that over the past several decades many risk or protective factors have been studied in relation to cognitive impairment, dementia (including AD) and cognitive decline. Overall, these studies indicate that modifiable factors including individuals’ socio-economic, behavioral characteristics and dietary intake seem to affect people’s cognitive ability and change over time, as well as the incidence of cognitive impairment, all-cause dementia and AD. It is worth noting, however, that some of the diagnostic criteria for dementia, AD and MCI have changed over time, particularly between the 1990s and the more recent years, as shown in Table 1.

In total, 247 studies were retrieved for systematic review. When conducting consistency analysis for each risk factor/design dyad, we found the % of studies with positive finding, given hypothesis, for most outcomes and study participants to range from ~38.9% for caffeine (27.3 for cohort studies (n = 11), 57.1% for cross-sectional studies(n = 7)) to ~89% for physical activity(87.5% for cohort studies(n = 24); 100% for cross-sectional studies(n = 4)). Consistency analysis confirmed that education-related studies had a significantly higher propensity for a positive or partially positive finding compared to caffeine, smoking and antioxidant-related studies. Meta-analysis of 31 studies with incident AD and selected risk/protective factors yielded pooled RR and 95% CI as follows: RR = 1.99(1.30, 3.04) for low(risk factor) vs. higher education (n = 4 studies; Q = 11.33, p = 0.010); RR = 1.37(1.23, 1.52) for smoking status (current or ever(risk factor) vs. never smokers (n = 9 studies, Q = 36.2, p < 0.001); RR = 0.58(0.49, 0.70) for higher physical activity(protective factor) vs. lower (n = 8 studies, Q = 3.2, p = 0.867), RR = 0.67(0.47,0.96) for higher intake of n-3 fatty acids(protective factor) vs. lower (n = 5, Q = 7.4, p = 0.116), and RR = 1.93(1.50, 2.49) for high levels of plasma Hcy(risk factor) vs. lower (n = 6 data points; Q = 2.64, p = 0.620). Given the observed prevalence of exposure from the largest study per risk factor included in each meta-analysis, the population attributable risk percent (PAR%) with its 95% CI was estimated as follows: for low education: 24.0% with a 95% CI: 8.4-39.6; for mid-life smoking it was 31.0% with a 95% CI: 17.9-44.3; for physical activity (lower vs. higher) it was 31.9% with 95% CI: 22.7-41.2; for high vs. low Hcy, it was 21.7% with a 95% CI: 12.8-30.6; for lower vs. higher fish consumption (<weekly vs. ≥weekly), it was 21.9% with 95% CI:4.7-39.1. There was no significant publication bias, taking all selected risk factors for incident AD together.

A large number of epidemiologic studies were initially conducted to examine the effects of socio-economic factors, mainly educational attainment, and were later used to assess the validity of alternative hypotheses regarding the presence of behavioral or health-related mediating factors. To this end, several behavioral and nutritional risk factors were studied in relation to various cognitive outcomes. For instance, it was hypothesized that low SES was associated with higher prevalence of smoking which in turn may affect cognitive performance and change over time. While few studies found weak or no association between smoking and cognitive decline, many others found a positive association whereby smoking increased the risk of decline. Alcohol was found in general to have a U-shaped association with the risk of decline, while caffeine was shown to increase perceptual speed and vigilance as well as memory and other more complex functions in at least two cohort studies and one cross-sectional study. Physical activity was shown to protect against cognitive decline as corroborated by a number of prospective cohort studies.

Among nutritional factors, dietary and supplemental antioxidants were shown in some studies to reduce the risk of cognitive decline while in others they showed no appreciable effect. Other micronutrients including B-Vitamins and folate were shown to be protective against cognitive decline, through their dampening effect on plasma Hcy which was shown to consistently increase the risk of dementia, particularly of the AD type. In addition, studies show that n-3 fatty acids with their anti-inflammatory and cardio-protective properties can help reduce the risk of cognitive decline and impairment in some studies but not in others. Among nutritional factors, caffeine seems to be the factor hypothesized to have a protective effect with the smallest number of current studies.

Conclusions

In conclusion, the consistency of findings between studies varied for each selected risk or protective modifiable factors (highest consistency observed for physical activity). Secondly, a moderate to strong association was observed between some selected factors and incident AD (strongest for low education and elevated Hcy). Combining both criteria (strength of association in the case of incident AD and consistency overall), the strongest evidence thus far is an increased risk with elevated plasma Hcy levels or lower educational attainment and a lowered risk with increased physical activity. Nevertheless, more studies are needed to verify the consistency, particularly regarding caffeine. A comprehensive meta-analysis requires additional research for certain risk factors of incident AD or dementia. For incident AD, selected risk factors may potentially account on average for 21.7%-31.9% of AD cases for each risk factor considered (with 95% CI: 8.4%-44.3%) (highest for mid-life smoking and physical activity), given the estimated prevalence of those factors from the largest available study. Thus, on average, one in five to one in three cases of AD can potentially be averted if those risk factors were eliminated from populations with comparable exposure prevalence.

Abbreviations

AD: Alzheimer’s disease; VaD: Vascular dementia; DLB: Dementia with Lewy bodies; PD-D: Parkinson’s disease with dementia; MD: Mixed dementia; FTD: Fronot-parietal dementia; OD: Other dementia; MCI: Mild cognitive impairment; ADDTC: Alzheimer's disease diagnostic and treatment centers; DSM-IV: Diagnostic and statistical manual, 4th edition; ICD-10: International classification of disease, 10th edition; NINCDS-ADRDA: National Institute of neurological and communicative disorders and stroke -- the Alzheimer's disease and related disorders association; NINDS-AIREN: National institute of neurological and communicative disorders and stroke--Association Internationale pour la Recherche et l’Enseignement en Neurosciences; ApoE: Apolipoprotein E; PAR%: Population attributable risk percent; OR: Odd ratio; RR: Relative risk; HR: Hazard ratio; CI: Confidence interval; Prexp: Prevalence of each exposure; SE: Standard errors; SD: Standard deviation; Edu: Education; Smok: Smoking status; Alco: Alcohol consumption; PA: Physical activity; CAFF: Caffeine consumption; Antiox: Antioxidants; N-3 Fa: n-3 fatty acids; SES: Socio-economic status; SEP: Socio-economic position; Hcy: Homocysteine; EPA: Eicosapentanoic acid; DHA: Docosahexaenoic acid; DGLA: Dihomogaminalinolenic acid; GLA: Gamma-linoleic acid; AA: Arachidonic acid; PUFA: Polyunsaturated fatty acid; MUFA: monounsaturated fatty acid; MMSE: Mini-mental state examination; B: Both; M: Men; W: Women; UK: United Kingdom; US: United States.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MAB: conceptualization, literature search and review, plan of analysis, data management, statistical analysis (including meta-analysis), writing of the manuscript, revision of the manuscript. HAB: Literature search and review, plan of analysis, writing of parts of the manuscript, revision of the manuscript. AG: Literature search and review, plan of analysis, writing of parts of the manuscript, revision of the manuscript. AT: Literature search and reivew, writing of parts of the manuscript, revision of the manuscript. ABZ: Plan of analysis, write-up of parts of the manuscript, revision of the manuscript. YW: Plan of analysis, write-up of parts of the manuscript, revision of the manuscript. All authors read and approved the final manuscript.

Authors’ information

Youfa Wang and Alan B Zonderman are senior authors.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2458/14/643/prepub

References 307

  1. 1.

    de Champlain J Wu R Girouard H Karas M ELM A Laplante MA Wu L Oxidative stress in hypertensionClin Exp Hypertens2004 26593601

    Not in our library10.1081/ceh-200031904

  2. 2.

    Verhaeghen P Salthouse TA Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural modelsPsychol Bull1997 122231249

    Not in our library10.1037/0033-2909.122.3.231

  3. 3.

    Moritz DJ Kasl SV Berkman LF Cognitive functioning and the incidence of limitations in activities of daily living in an elderly community sampleAm J Epidemiol1995 1414149

    Not in our library10.1093/oxfordjournals.aje.a117344

  4. 4.

    Lobo A Launer LJ Fratiglioni L Andersen K Di Carlo A Breteler MM Copeland JR Dartigues JF Jagger C Martinez-Lage J Soininen H Hofman A Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research GroupNeurology2000 54S49

    Not in our library

  5. 5.

    Li G Shen YC Chen CH Zhao YW Li SR Lu M An epidemiological survey of age-related dementia in an urban area of BeijingActa Psychiatr Scand1989 79557563

    Not in our library10.1111/j.1600-0447.1989.tb10303.x

  6. 6.

    Fichter MM Meller I Schroppel H Steinkirchner R Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidityBr J Psychiatry1995 166621629

    Not in our library10.1192/bjp.166.5.621

  7. 7.

    Ankri J Poupard M Prevalence and incidence of dementia among the very old. Review of the literatureRev Epidemiol Sante Publique2003 51349360

    Not in our library

  8. 8.

    Jorm AF Jolley D The incidence of dementia: a meta-analysisNeurology1998 51728733

    Not in our library10.1212/wnl.51.3.728

  9. 9.

    Ott A Breteler MM van Harskamp F Claus JJ van der Cammen TJ Grobbee DE Hofman A Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam studyBMJ1995 310970973

    Not in our library10.1136/bmj.310.6985.970

  10. 10.

    Liu HC Lin KN Teng EL Wang SJ Fuh JL Guo NW Chou P Hu HH Chiang BN Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individualsJ Am Geriatr Soc1995 43144149

    Not in our library10.1111/j.1532-5415.1995.tb06379.x

  11. 11.

    McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of health and human services task force on Alzheimer's diseaseNeurology1984 34939944

    Not in our library10.1212/wnl.34.7.939

  12. 12.

    McKhann GM Knopman DS Chertkow H Hyman BT Jack CR Jr Kawas CH Klunk WE Koroshetz WJ Manly JJ Mayeux R Mohs RC Morris JC Rossor MN Scheltens P Carrillo MC Thies B Weintraub S Phelps CH The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimers Dement2011 7263269

    Not in our library10.1016/j.jalz.2011.03.005

  13. 13.

    Roman GC Tatemichi TK Erkinjuntti T Cummings JL Masdeu JC Garcia JH Amaducci L Orgogozo JM Brun A Hofman A Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshopNeurology1993 43250260

    Not in our library10.1212/wnl.43.2.250

  14. 14.

    Hachinski VC Iliff LD Zilhka E Du Boulay GH McAllister VL Marshall J Russell RW Symon L Cerebral blood flow in dementiaArch Neurol1975 32632637

    Not in our library10.1001/archneur.1975.00490510088009

  15. 15.

    The Lund and Manchester GroupsClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groupsJ Neurol Neurosurg Psychiatry1994 57416418

    Not in our library10.1136/jnnp.57.4.416

  16. 16.

    McKeith IG Galasko D Kosaka K Perry EK Dickson DW Hansen LA Salmon DP Lowe J Mirra SS Byrne EJ Lennox G Quinn NP Edwardson JA Ince PG Bergeron C Burns A Miller BL Lovestone S Collerton D Jansen EN Ballard C de Vos RA Wilcock GK Jellinger KA Perry RH Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopNeurology1996 4711131124

    Not in our library10.1212/wnl.47.5.1113

  17. 17.

    Crecelius C Diagnosis and treatment of non-Alzheimer's dementiasJ Am Med Dir Assoc2003 4H2529

    Not in our library10.1097/01.jam.0000078013.50275.ff

  18. 18.

    Zekry D Hauw JJ Gold G Mixed dementia: epidemiology, diagnosis, and treatmentJ Am Geriatr Soc2002 5014311438

    Not in our library10.1046/j.1532-5415.2002.50367.x

  19. 19.

    Gorelick PB Scuteri A Black SE Decarli C Greenberg SM Iadecola C Launer LJ Laurent S Lopez OL Nyenhuis D Petersen RC Schneider JA Tzourio C Arnett DK Bennett DA Chui HC Higashida RT Lindquist R Nilsson PM Roman GC Sellke FW Seshadri S American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and AnesthesiaVascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke associationStroke2011 4226722713

    Not in our library10.1161/str.0b013e3182299496

  20. 20.

    Barnes DE Yaffe K The projected effect of risk factor reduction on Alzheimer's disease prevalenceLancet Neurol2011 10819828

    Not in our library10.1016/s1474-4422(11)70072-2

  21. 21.

    Zhang MY Katzman R Salmon D Jin H Cai GJ Wang ZY Qu GY Grant I Yu E Levy P The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and educationAnn Neurol1990 27428437

    Not in our library10.1002/ana.410270412

  22. 22.

    Ogunniyi A Lekwauwa UG Osuntokun BO Influence of education on aspects of cognitive functions in non-demented elderly NigeriansNeuroepidemiology1991 10246250

    Not in our library10.1159/000110280

  23. 23.

    Dealberto MJ Gagnon M Barberger-Gateau P Dartigues JF Alperovitch A [Influence of educational status on a screening test for dementia, the mini-mental state examination]Rev Epidemiol Sante Publique1992 4093101

    Not in our library

  24. 24.

    Koivisto K Helkala EL Reinikainen KJ Hanninen T Mykkanen L Laakso M Pyorala K Riekkinen PJ Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological testsJ Geriatr Psychiatry Neurol1992 5162171

    Not in our library10.1177/002383099200500306

  25. 25.

    Evans DA Beckett LA Albert MS Hebert LE Scherr PA Funkenstein HH Taylor JO Level of education and change in cognitive function in a community population of older personsAnn Epidemiol1993 37177

    Not in our library10.1016/1047-2797(93)90012-s

  26. 26.

    Paykel ES Brayne C Huppert FA Gill C Barkley C Gehlhaar E Beardsall L Girling DM Pollitt P O'Connor D Incidence of dementia in a population older than 75 years in the United KingdomArch Gen Psychiatry1994 51325332

    Not in our library10.1001/archpsyc.1994.03950040069009

  27. 27.

    White L Katzman R Losonczy K Salive M Wallace R Berkman L Taylor J Fillenbaum G Havlik R Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderlyJ Clin Epidemiol1994 47363374

    Not in our library10.1016/0895-4356(94)90157-0

  28. 28.

    Cobb JL Wolf PA Au R White R D'Agostino RB The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham StudyNeurology1995 4517071712

    Not in our library10.1212/wnl.45.9.1707

  29. 29.

    Farmer ME Kittner SJ Rae DS Bartko JJ Regier DA Education and change in cognitive function. The epidemiologic catchment area studyAnn Epidemiol1995 517

    Not in our library10.1016/1047-2797(94)00047-w

  30. 30.

    Callahan CM Hall KS Hui SL Musick BS Unverzagt FW Hendrie HC Relationship of age, education, and occupation with dementia among a community-based sample of African AmericansArch Neurol1996 53134140

    Not in our library10.1001/archneur.1996.00550020038013

  31. 31.

    Hanninen T Koivisto K Reinikainen KJ Helkala EL Soininen H Mykkanen L Laakso M Riekkinen PJ Prevalence of ageing-associated cognitive decline in an elderly populationAge Ageing1996 25201205

    Not in our library10.1093/ageing/25.3.201

  32. 32.

    Christensen H Korten AE Jorm AF Henderson AS Jacomb PA Rodgers B Mackinnon AJ Education and decline in cognitive performance: compensatory but not protectiveInt J Geriatr Psychiatry1997 12323330

    Not in our library10.1002/(sici)1099-1166(199703)12:3<323::aid-gps492>3.0.co;2-n

  33. 33.

    Evans DA Hebert LE Beckett LA Scherr PA Albert MS Chown MJ Pilgrim DM Taylor JO Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older personsArch Neurol1997 5413991405

    Not in our library10.1001/archneur.1997.00550230066019

  34. 34.

    Freidl W Schmidt R Stronegger WJ Reinhart B The impact of sociodemographic, environmental, and behavioral factors, and cerebrovascular risk factors as potential predictors of the mattis dementia rating scaleJ Gerontol A Biol Sci Med Sci1997 52M111116

    Not in our library10.1093/gerona/52a.2.m111

  35. 35.

    Kalmijn S Feskens EJ Launer LJ Kromhout D Longitudinal study of the effect of apolipoprotein e4 allele on the association between education and cognitive decline in elderly menBMJ1997 3143435

    Not in our library10.1136/bmj.314.7073.34

  36. 36.

    Kilander L Nyman H Boberg M Lithell H Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohort of 70-year-old menJ Intern Med1997 242313321

    Not in our library10.1046/j.1365-2796.1997.00196.x

  37. 37.

    Schmand B Smit J Lindeboom J Smits C Hooijer C Jonker C Deelman B Low education is a genuine risk factor for accelerated memory decline and dementiaJ Clin Epidemiol1997 5010251033

    Not in our library10.1016/s0895-4356(97)00121-2

  38. 38.

    Schmand B Smit JH Geerlings MI Lindeboom J The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesisPsychol Med1997 2713371344

    Not in our library10.1017/s0033291797005461

  39. 39.

    Cerhan JR Folsom AR Mortimer JA Shahar E Knopman DS McGovern PG Hays MA Crum LD Heiss G Correlates of cognitive function in middle-aged adults. Atherosclerosis risk in communities (ARIC) study investigatorsGerontology1998 4495105

    Not in our library10.1159/000021991

  40. 40.

    De Ronchi D Fratiglioni L Rucci P Paternico A Graziani S Dalmonte E The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic statusNeurology1998 5012311238

    Not in our library10.1212/wnl.50.5.1231

  41. 41.

    Lin RT Lai CL Tai CT Liu CK Yen YY Howng SL Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanizationJ Neurol Sci1998 1606775

    Not in our library10.1016/s0022-510x(98)00225-1

  42. 42.

    Lyketsos CG Chen LS Anthony JC Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore epidemiologic catchment area studyAm J Psychiatry1999 1565865

    Not in our library10.1176/ajp.156.1.58

  43. 43.

    Letenneur L Gilleron V Commenges D Helmer C Orgogozo JM Dartigues JF Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID projectJ Neurol Neurosurg Psychiatry1999 66177183

    Not in our library10.1136/jnnp.66.2.177

  44. 44.

    Ott A van Rossum CT van Harskamp F van de Mheen H Hofman A Breteler MM Education and the incidence of dementia in a large population-based study: the Rotterdam studyNeurology1999 52663666

    Not in our library10.1212/wnl.52.3.663

  45. 45.

    Aevarsson O Skoog I A longitudinal population study of the mini-mental state examination in the very old: relation to dementia and educationDement Geriatr Cogn Disord2000 11166175

    Not in our library10.1159/000017231

  46. 46.

    Qiu C Backman L Winblad B Aguero-Torres H Fratiglioni L The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen projectArch Neurol2001 5820342039

    Not in our library10.1001/archneur.58.12.2034

  47. 47.

    Alvarado BE Zunzunegui MV Del Ser T Beland F Cognitive decline is related to education and occupation in a Spanish elderly cohortAging Clin Exp Res2002 14132142

    Not in our library10.1007/bf03324426

  48. 48.

    Cagney KA Lauderdale DS Education, wealth, and cognitive function in later lifeJ Gerontol B Psychol Sci Soc Sci2002 57P163172

    Not in our library10.1093/geronb/57.2.p163

  49. 49.

    Herrera E Jr Caramelli P Silveira AS Nitrini R Epidemiologic survey of dementia in a community-dwelling Brazilian populationAlzheimer Dis Assoc Disord2002 16103108

    Not in our library10.1097/00002093-200204000-00007

  50. 50.

    Ravaglia G Forti P Maioli F Sacchetti L Mariani E Nativio V Talerico T Vettori C Macini PL Education, occupation, and prevalence of dementia: findings from the Conselice studyDement Geriatr Cogn Disord2002 1490100

    Not in our library10.1159/000064930

  51. 51.

    Wight RG Aneshensel CS Seeman TE Educational attainment, continued learning experience, and cognitive function among older menJ Aging Health2002 14211236

    Not in our library10.1177/089826430201400203

  52. 52.

    Lee S Kawachi I Berkman LF Grodstein F Education, other socioeconomic indicators, and cognitive functionAm J Epidemiol2003 157712720

    Not in our library10.1093/aje/kwg042

  53. 53.

    Seeman TE Huang MH Bretsky P Crimmins E Launer L Guralnik JM Education and APOE-e4 in longitudinal cognitive decline: MacArthur studies of successful agingJ Gerontol B Psychol Sci Soc Sci2005 60P7483

    Not in our library10.1093/geronb/60.2.p74

  54. 54.

    Lee S Buring JE Cook NR Grodstein F The relation of education and income to cognitive function among professional womenNeuroepidemiology2006 2693101

    Not in our library10.1159/000090254

  55. 55.

    Shadlen MF Siscovick D Fitzpatrick AL Dulberg C Kuller LH Jackson S Education, cognitive test scores, and black-white differences in dementia riskJ Am Geriatr Soc2006 54898905

    Not in our library10.1111/j.1532-5415.2006.00747.x

  56. 56.

    Zhang ZX Zahner GE Román GC Liu XH Wu CB Hong Z Hong X Tang MN Zhou B Qu QM Zhang XJ Li H Socio-demographic variation of dementia subtypes in china: methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and XianNeuroepidemiology2006 27177187

    Not in our library10.1159/000096131

  57. 57.

    Zhou DF Wu CS Qi H Fan JH Sun XD Como P Qiao YL Zhang L Kieburtz K Prevalence of dementia in rural China: impact of age, gender and educationActa Neurol Scand2006 114273280

    Not in our library10.1111/j.1600-0404.2006.00641.x

  58. 58.

    Galasko D Salmon D Gamst A Olichney J Thal LJ Silbert L Kaye J Brooks P Adonay R Craig UK Schellenberg G Borenstein AR Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOENeurology2007 6817721781

    Not in our library10.1212/01.wnl.0000262028.16738.64

  59. 59.

    van Hooren SA Valentijn AM Bosma H Ponds RW van Boxtel MP Jolles J Cognitive functioning in healthy older adults aged 64–81: a cohort study into the effects of age, sex, and educationNeuropsychol Dev Cogn B Aging Neuropsychol Cogn2007 144054

    Not in our library10.1080/138255890969483

  60. 60.

    Christensen H Batterham PJ Mackinnon AJ Anstey KJ Wen W Sachdev PS Education, atrophy, and cognitive change in an epidemiological sample in early old ageAm J Geriatr Psychiatry2009 17218226

    Not in our library10.1097/jgp.0b013e3181961a84

  61. 61.

    Dotson VM Kitner-Triolo MH Evans MK Zonderman AB Effects of race and socioeconomic status on the relative influence of education and literacy on cognitive functioningJ Int Neuropsychol Soc2009 15580589

    Not in our library10.1017/s1355617709090821

  62. 62.

    Gavrila D Antunez C Tormo MJ Carles R Garcia Santos JM Parrilla G Fortuna L Jimenez J Salmeron D Navarro C Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna studyActa Neurol Scand2009 120300307

    Not in our library10.1111/j.1600-0404.2009.01283.x

  63. 63.

    Peters R Beckett N Geneva M Tzekova M Lu FH Poulter R Gainsborough N Williams B de Vernejoul MC Fletcher A Bulpitt C Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVETAge Ageing2009 38521527

    Not in our library10.1093/ageing/afp094

  64. 64.

    Wilson RS Hebert LE Scherr PA Barnes LL de Leon CF M Evans DA Educational attainment and cognitive decline in old ageNeurology2009 72460465

    Not in our library10.1212/01.wnl.0000341782.71418.6c

  65. 65.

    Hamid TA Krishnaswamy S Abdullah SS Momtaz YA Sociodemographic risk factors and correlates of dementia in older MalaysiansDement Geriatr Cogn Disord2010 30533539

    Not in our library10.1159/000321672

  66. 66.

    Mathuranath PS Cherian PJ Mathew R Kumar S George A Alexander A Ranjith N Sarma PS Dementia in Kerala, South India: prevalence and influence of age, education and genderInt J Geriatr Psychiatry2010 25290297

    Not in our library10.1002/gps.2338

  67. 67.

    Scazufca M Almeida OP Menezes PR The role of literacy, occupation and income in dementia prevention: the Sao Paulo ageing & health study (SPAH)Int Psychogeriatr2010 2212091215

    Not in our library10.1017/s1041610210001213

  68. 68.

    Castro-Costa E Dewey ME Uchoa E Firmo JO Lima-Costa MF Stewart R Trajectories of cognitive decline over 10 years in a Brazilian elderly population: the Bambui cohort study of agingCad Saude Publica2011 27Suppl 3S345350

    Not in our library10.1590/s0102-311x2011001500004

  69. 69.

    Marengoni A Fratiglioni L Bandinelli S Ferrucci L Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti area (InCHIANTI) studyJ Alzheimers Dis2011 24559568

    Not in our library10.3233/jad-2011-101863

  70. 70.

    Mejia-Arango S Gutierrez LM Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican health and aging studyJ Aging Health2011 2310501074

    Not in our library10.1177/0898264311421199

  71. 71.

    Zahodne LB Glymour MM Sparks C Bontempo D Dixon RA MacDonald SW Manly JJ Education does not slow cognitive decline with aging: 12-year evidence from the victoria longitudinal studyJ Int Neuropsychol Soc2011 1710391046

    Not in our library10.1017/s1355617711001044

  72. 72.

    Herbert LE Scherr PA Beckett LA Albert MS Rosner B Taylor JO Evans DA Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older personsAm J Epidemiol1993 137881891

    Not in our library10.1093/oxfordjournals.aje.a116749

  73. 73.

    Letenneur L Dartigues JF Commenges D Barberger-Gateau P Tessier JF Orgogozo JM Tobacco consumption and cognitive impairment in elderly people. A population-based studyAnn Epidemiol1994 4449454

    Not in our library10.1016/1047-2797(94)90004-3

  74. 74.

    Ford AB Mefrouche Z Friedland RP Debanne SM Smoking and cognitive impairment: a population-based studyJ Am Geriatr Soc1996 44905909

    Not in our library10.1111/j.1532-5415.1996.tb01858.x

  75. 75.

    Galanis DJ Petrovitch H Launer LJ Harris TB Foley DJ White LR Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia Aging StudyAm J Epidemiol1997 145507515

    Not in our library10.1093/oxfordjournals.aje.a009138

  76. 76.

    Broe GA Creasey H Jorm AF Bennett HP Casey B Waite LM Grayson DA Cullen J Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumptionAust N Z J Public Health1998 22621623

    Not in our library10.1111/j.1467-842x.1998.tb01449.x

  77. 77.

    Edelstein SL Kritz-Silverstein D Barrett-Connor E Prospective association of smoking and alcohol use with cognitive function in an elderly cohortJ Womens Health1998 712711281

    Not in our library10.1089/jwh.1998.7.1271

  78. 78.

    Ott A Slooter AJ Hofman A van Harskamp F Witteman JC Van Broeckhoven C van Duijn CM Breteler MM Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam studyLancet1998 35118401843

    Not in our library10.1016/s0140-6736(97)07541-7

  79. 79.

    Carmelli D Swan GE Reed T Schellenberg GD Christian JC The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive functionNeuroepidemiology1999 18125133

    Not in our library10.1159/000026204

  80. 80.

    Elwood PC Gallacher JE Hopkinson CA Pickering J Rabbitt P Stollery B Brayne C Huppert FA Bayer A Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohortJ Epidemiol Community Health1999 53914

    Not in our library10.1136/jech.53.1.9

  81. 81.

    Cervilla JA Prince M Mann A Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak projectJ Neurol Neurosurg Psychiatry2000 68622626

    Not in our library10.1136/jnnp.68.5.622

  82. 82.

    Doll R Peto R Boreham J Sutherland I Smoking and dementia in male British doctors: prospective studyBMJ2000 32010971102

    Not in our library10.1136/bmj.320.7242.1097

  83. 83.

    Kalmijn S van Boxtel MP Verschuren MW Jolles J Launer LJ Cigarette smoking and alcohol consumption in relation to cognitive performance in middle ageAm J Epidemiol2002 156936944

    Not in our library10.1093/aje/kwf135

  84. 84.

    Chen WT Wang PN Wang SJ Fuh JL Lin KN Liu HC Smoking and cognitive performance in the community elderly: a longitudinal studyJ Geriatr Psychiatry Neurol2003 161822

    Not in our library10.1177/0891988702250510

  85. 85.

    Richards M Jarvis MJ Thompson N Wadsworth ME Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort studyAm J Public Health2003 93994998

    Not in our library10.2105/ajph.93.6.994

  86. 86.

    Tyas SL White LR Petrovitch H Webster Ross G Foley DJ Heimovitz HK Launer LJ Mid-life smoking and late-life dementia: the Honolulu-Asia aging studyNeurobiol Aging2003 24589596

    Not in our library10.1016/s0197-4580(02)00156-2

  87. 87.

    Zhou H Deng J Li J Wang Y Zhang M He H Study of the relationship between cigarette smoking, alcohol drinking and cognitive impairment among elderly people in ChinaAge Ageing2003 32205210

    Not in our library10.1093/ageing/32.2.205

  88. 88.

    Juan D Zhou DH Li J Wang JY Gao C Chen M A 2-year follow-up study of cigarette smoking and risk of dementiaEur J Neurol2004 11277282

    Not in our library10.1046/j.1468-1331.2003.00779.x

  89. 89.

    Ott A Andersen K Dewey ME Letenneur L Brayne C Copeland JR Dartigues JF Kragh-Sorensen P Lobo A Martinez-Lage JM Stijnen T Hofman A Launer LJ EURODEM Incidence Research GroupEffect of smoking on global cognitive function in nondemented elderlyNeurology2004 62920924

    Not in our library10.1212/01.wnl.0000115110.35610.80

  90. 90.

    Solfrizzi V Panza F Colacicco AM D'Introno A Capurso C Torres F Grigoletto F Maggi S Del Parigi A Reiman EM Caselli RJ Scafato E Farchi G Capurso A Italian Longitudinal Study on Aging Working GroupVascular risk factors, incidence of MCI, and rates of progression to dementiaNeurology2004 6318821891

    Not in our library10.1212/01.wnl.0000144281.38555.e3

  91. 91.

    Aleman A Muller M de Haan EH van der Schouw YT Vascular risk factors and cognitive function in a sample of independently living menNeurobiol Aging2005 26485490

    Not in our library10.1016/j.neurobiolaging.2004.05.005

  92. 92.

    Reitz C Luchsinger J Tang MX Mayeux R Effect of smoking and time on cognitive function in the elderly without dementiaNeurology2005 65870875

    Not in our library10.1212/01.wnl.0000176057.22827.b7

  93. 93.

    Whitmer RA Sidney S Selby J Johnston SC Yaffe K Midlife cardiovascular risk factors and risk of dementia in late lifeNeurology2005 64277281

    Not in our library10.1212/01.wnl.0000149519.47454.f2

  94. 94.

    Stewart MC Deary IJ Fowkes FG Price JF Relationship between lifetime smoking, smoking status at older age and human cognitive functionNeuroepidemiology2006 268392

    Not in our library10.1159/000090253

  95. 95.

    Reitz C den Heijer T van Duijn C Hofman A Breteler MM Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam studyNeurology2007 699981005

    Not in our library10.1212/01.wnl.0000271395.29695.9a

  96. 96.

    Nooyens AC van Gelder BM Verschuren WM Smoking and cognitive decline among middle-aged men and women: the Doetinchem cohort studyAm J Public Health2008 9822442250

    Not in our library10.2105/ajph.2007.130294

  97. 97.

    Sabia S Marmot M Dufouil C Singh-Manoux A Smoking history and cognitive function in middle age from the Whitehall II studyArch Intern Med2008 16811651173

    Not in our library10.1001/archinte.168.11.1165

  98. 98.

    Alonso A Mosley TH Jr Gottesman RF Catellier D Sharrett AR Coresh J Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis risk in communities (ARIC) studyJ Neurol Neurosurg Psychiatry2009 8011941201

    Not in our library10.1136/jnnp.2009.176818

  99. 99.

    Collins N Sachs-Ericsson N Preacher KJ Sheffield KM Markides K Smoking increases risk for cognitive decline among community-dwelling older Mexican AmericansAm J Geriatr Psychiatry2009 17934942

    Not in our library10.1097/jgp.0b013e3181b0f8df

  100. 100.

    Huang CQ Dong BR Zhang YL Wu HM Liu QX Association of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenariansCogn Behav Neurol2009 22190196

    Not in our library10.1097/wnn.0b013e3181b2790b

  101. 101.

    Rusanen M Rovio S Ngandu T Nissinen A Tuomilehto J Soininen H Kivipelto M Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia studyDement Geriatr Cogn Disord2010 30277284

    Not in our library10.1159/000320484

  102. 102.

    Wang CC Lu TH Liao WC Yuan SC Kuo PC Chuang HL Lee MC Yen CH Cigarette smoking and cognitive impairment: a 10-year cohort study in TaiwanArch Gerontol Geriatr2010 51143148

    Not in our library10.1016/j.archger.2009.09.041

  103. 103.

    Ronnemaa E Zethelius B Lannfelt L Kilander L Vascular risk factors and dementia: 40-year follow-up of a population-based cohortDement Geriatr Cogn Disord2011 31460466

    Not in our library10.1159/000330020

  104. 104.

    Rusanen M Kivipelto M Quesenberry CP Jr Zhou J Whitmer RA Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementiaArch Intern Med2011 171333339

    Not in our library10.1001/archinternmed.2010.393

  105. 105.

    Sabia S Elbaz A Dugravot A Head J Shipley M Hagger-Johnson G Kivimaki M Singh-Manoux A Impact of smoking on cognitive decline in early old age: the Whitehall II cohort studyArch Gen Psychiatry2012 69627635

    Not in our library10.1001/archgenpsychiatry.2011.2016

  106. 106.

    Hendrie HC Gao S Hall KS Hui SL Unverzagt FW The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black AmericansJ Am Geriatr Soc1996 4411581165

    Not in our library10.1111/j.1532-5415.1996.tb01364.x

  107. 107.

    Dufouil C Ducimetiere P Alperovitch A Sex differences in the association between alcohol consumption and cognitive performance. EVA study group. Epidemiology of vascular agingAm J Epidemiol1997 146405412

    Not in our library10.1093/oxfordjournals.aje.a009293

  108. 108.

    Elias PK Elias MF D'Agostino RB Silbershatz H Wolf PA Alcohol consumption and cognitive performance in the Framingham heart studyAm J Epidemiol1999 150580589

    Not in our library10.1093/oxfordjournals.aje.a010056

  109. 109.

    Bond GE Burr R McCurry SM Graves AB Larson EB Alcohol, aging, and cognitive performance in a cohort of Japanese Americans aged 65 and older: the Kame projectInt Psychogeriatr2001 13207223

    Not in our library10.1017/s1041610201007591

  110. 110.

    Zuccala G Onder G Pedone C Cesari M Landi F Bernabei R Cocchi A Dose-related impact of alcohol consumption on cognitive function in advanced age: results of a multicenter surveyAlcohol Clin Exp Res2001 2517431748

    Not in our library

  111. 111.

    Leroi I Sheppard JM Lyketsos CG Cognitive function after 11.5 years of alcohol use: relation to alcohol useAm J Epidemiol2002 156747752

    Not in our library10.1093/aje/kwf107

  112. 112.

    Krahn D Freese J Hauser R Barry K Goodman B Alcohol use and cognition at mid-life: the importance of adjusting for baseline cognitive ability and educational attainmentAlcohol Clin Exp Res2003 2711621166

    Not in our library10.1097/01.alc.0000078060.18662.c1

  113. 113.

    Anttila T Helkala EL Viitanen M Kareholt I Fratiglioni L Winblad B Soininen H Tuomilehto J Nissinen A Kivipelto M Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based studyBMJ2004 329539

    Not in our library10.1136/bmj.38181.418958.be

  114. 114.

    Bond GE Burr R McCurry SM Rice MM Borenstein AR Kukull WA Teri L Bowen JD McCormick WC Larson EB Alcohol, gender, and cognitive performance: a longitudinal study comparing older Japanese and non-Hispanic white AmericansJ Aging Health2004 16615640

    Not in our library10.1177/0898264304268587

  115. 115.

    Britton A Singh-Manoux A Marmot M Alcohol consumption and cognitive function in the Whitehall II studyAm J Epidemiol2004 160240247

    Not in our library10.1093/aje/kwh206

  116. 116.

    Bond GE Burr RL McCurry SM Rice MM Borenstein AR Larson EB Alcohol and cognitive performance: a longitudinal study of older Japanese Americans. The Kame projectInt Psychogeriatr2005 17653668

    Not in our library10.1017/s1041610205001651

  117. 117.

    Ganguli M Vander Bilt J Saxton JA Shen C Dodge HH Alcohol consumption and cognitive function in late life: a longitudinal community studyNeurology2005 6512101217

    Not in our library10.1212/01.wnl.0000180520.35181.24

  118. 118.

    Richards M Hardy R Wadsworth ME Alcohol consumption and midlife cognitive change in the British 1946 birth cohort studyAlcohol Alcohol2005 40112117

    Not in our library10.1093/alcalc/agh126

  119. 119.

    Rodgers B Windsor TD Anstey KJ Dear KB FJ A Christensen H Non-linear relationships between cognitive function and alcohol consumption in young, middle-aged and older adults: the PATH through life projectAddiction2005 10012801290

    Not in our library10.1111/j.1360-0443.2005.01158.x

  120. 120.

    Stampfer MJ Kang JH Chen J Cherry R Grodstein F Effects of moderate alcohol consumption on cognitive function in womenN Engl J Med2005 352245253

    Not in our library10.1056/nejmoa041152

  121. 121.

    Reid MC Van Ness PH Hawkins KA Towle V Concato J Guo Z Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary careJ Geriatr Psychiatry Neurol2006 1998105

    Not in our library10.1177/0891988706286513

  122. 122.

    Wright CB Elkind MS Luo X Paik MC Sacco RL Reported alcohol consumption and cognitive decline: the northern Manhattan studyNeuroepidemiology2006 27201207

    Not in our library10.1159/000096300

  123. 123.

    Ngandu T Helkala EL Soininen H Winblad B Tuomilehto J Nissinen A Kivipelto M Alcohol drinking and cognitive functions: findings from the cardiovascular risk factors aging and dementia (CAIDE) studyDement Geriatr Cogn Disord2007 23140149

    Not in our library10.1159/000097995

  124. 124.

    Solfrizzi V D'Introno A Colacicco AM Capurso C Del Parigi A Baldassarre G Scapicchio P Scafato E Amodio M Capurso A Panza F Alcohol consumption, mild cognitive impairment, and progression to dementiaNeurology2007 6817901799

    Not in our library10.1212/01.wnl.0000262035.87304.89

  125. 125.

    Xu G Liu X Yin Q Zhu W Zhang R Fan X Alcohol consumption and transition of mild cognitive impairment to dementiaPsychiatry Clin Neurosci2009 634349

    Not in our library10.1111/j.1440-1819.2008.01904.x

  126. 126.

    Au Yeung SL Jiang C Zhang W Lam TH Cheng KK Leung GM Schooling CM Moderate alcohol use and cognitive function in the Guangzhou Biobank cohort studyAnn Epidemiol2010 20873882

    Not in our library10.1016/j.annepidem.2010.06.005

  127. 127.

    Chan KK Chiu KC Chu LW Association between alcohol consumption and cognitive impairment in Southern Chinese older adultsInt J Geriatr Psychiatry2010 2512721279

    Not in our library10.1002/gps.2470

  128. 128.

    Corley J Jia X Brett CE Gow AJ Starr JM Kyle JA McNeill G Deary IJ Alcohol intake and cognitive abilities in old age: the Lothian birth cohort 1936 studyNeuropsychology2011 25166175

    Not in our library10.1037/a0021571

  129. 129.

    Gross AL Rebok GW Ford DE Chu AY Gallo JJ Liang KY Meoni LA Shihab HM Wang NY Klag MJ Alcohol consumption and domain-specific cognitive function in older adults: longitudinal data from the Johns Hopkins precursors studyJ Gerontol B Psychol Sci Soc Sci2011 663947

    Not in our library10.1093/geronb/gbq062

  130. 130.

    Sabia S Gueguen A Berr C Berkman L Ankri J Goldberg M Zins M Singh-Manoux A High alcohol consumption in middle-aged adults is associated with poorer cognitive performance only in the low socio-economic group. Results from the GAZEL cohort studyAddiction2011 10693101

    Not in our library10.1111/j.1360-0443.2010.03106.x

  131. 131.

    Zanjani F Downer BG Kruger TM Willis SL Schaie KW Alcohol effects on cognitive change in middle-aged and older adultsAging Ment Health2013 1711223

    Not in our library10.1080/13607863.2012.717254

  132. 132.

    Ho SC Woo J Sham A Chan SG Yu AL A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohortInt J Epidemiol2001 3013891396

    Not in our library10.1093/ije/30.6.1389

  133. 133.

    Laurin D Verreault R Lindsay J MacPherson K Rockwood K Physical activity and risk of cognitive impairment and dementia in elderly personsArch Neurol2001 58498504

    Not in our library10.1001/archneur.58.3.498

  134. 134.

    Schuit AJ Feskens EJ Launer LJ Kromhout D Physical activity and cognitive decline, the role of the apolipoprotein e4 alleleMed Sci Sports Exerc2001 33772777

    Not in our library10.1097/00005768-200105000-00015

  135. 135.

    Yaffe K Barnes D Nevitt M Lui LY Covinsky K A prospective study of physical activity and cognitive decline in elderly women: women who walkArch Intern Med2001 16117031708

    Not in our library10.1001/archinte.161.14.1703

  136. 136.

    Verghese J Lipton RB Katz MJ Hall CB Derby CA Kuslansky G Ambrose AF Sliwinski M Buschke H Leisure activities and the risk of dementia in the elderlyN Engl J Med2003 34825082516

    Not in our library10.1056/nejmoa022252

  137. 137.

    Abbott RD White LR Ross GW Masaki KH Curb JD Petrovitch H Walking and dementia in physically capable elderly menJAMA2004 29214471453

    Not in our library10.1001/jama.292.12.1447

  138. 138.

    Lytle ME Vander Bilt J Pandav RS Dodge HH Ganguli M Exercise level and cognitive decline: the MoVIES projectAlzheimer Dis Assoc Disord2004 185764

    Not in our library10.1097/01.wad.0000126614.87955.79

  139. 139.

    van Gelder BM Tijhuis MA Kalmijn S Giampaoli S Nissinen A Kromhout D Physical activity in relation to cognitive decline in elderly men: the FINE StudyNeurology2004 6323162321

    Not in our library10.1212/01.wnl.0000147474.29994.35

  140. 140.

    Weuve J Kang JH Manson JE Breteler MM Ware JH Grodstein F Physical activity, including walking, and cognitive function in older womenJAMA2004 29214541461

    Not in our library10.1001/jama.292.12.1454

  141. 141.

    Podewils LJ Guallar E Kuller LH Fried LP Lopez OL Carlson M Lyketsos CG Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition studyAm J Epidemiol2005 161639651

    Not in our library10.1093/aje/kwi092

  142. 142.

    Rovio S Kareholt I Helkala EL Viitanen M Winblad B Tuomilehto J Soininen H Nissinen A Kivipelto M Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's diseaseLancet Neurol2005 4705711

    Not in our library10.1016/s1474-4422(05)70198-8

  143. 143.

    Sturman MT Morris MC de Leon CF M Bienias JL Wilson RS Evans DA Physical activity, cognitive activity, and cognitive decline in a biracial community populationArch Neurol2005 6217501754

    Not in our library10.1001/archneur.62.11.1750

  144. 144.

    Karp A Paillard-Borg S Wang HX Silverstein M Winblad B Fratiglioni L Mental, physical and social components in leisure activities equally contribute to decrease dementia riskDement Geriatr Cogn Disord2006 216573

    Not in our library10.1159/000089919

  145. 145.

    Larson EB Wang L Bowen JD McCormick WC Teri L Crane P Kukull W Exercise is associated with reduced risk for incident dementia among persons 65 years of age and olderAnn Intern Med2006 1447381

    Not in our library10.7326/0003-4819-144-2-200601170-00004

  146. 146.

    Landi F Russo A Barillaro C Cesari M Pahor M Danese P Bernabei R Onder G Physical activity and risk of cognitive impairment among older persons living in the communityAging Clin Exp Res2007 19410416

    Not in our library10.1007/bf03324723

  147. 147.

    Psaltopoulou T Kyrozis A Stathopoulos P Trichopoulos D Vassilopoulos D Trichopoulou A Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition)Public Health Nutr2008 1110541062

    Not in our library10.1017/s1368980007001607

  148. 148.

    Taaffe DR Irie F Masaki KH Abbott RD Petrovitch H Ross GW White LR Physical activity, physical function, and incident dementia in elderly men: the Honolulu-Asia aging studyJ Gerontol A Biol Sci Med Sci2008 63529535

    Not in our library10.1093/gerona/63.5.529

  149. 149.

    Gallucci M Antuono P Ongaro F Forloni PL Albani D Amici GP Regini C Physical activity, socialization and reading in the elderly over the age of seventy: what is the relation with cognitive decline? Evidence from "The Treviso Longeva (TRELONG) study"Arch Gerontol Geriatr2009 48284286

    Not in our library10.1016/j.archger.2008.02.006

  150. 150.

    Scarmeas N Luchsinger JA Schupf N Brickman AM Cosentino S Tang MX Stern Y Physical activity, diet, and risk of Alzheimer diseaseJAMA2009 302627637

    Not in our library10.1001/jama.2009.1144

  151. 151.

    Yaffe K Fiocco AJ Lindquist K Vittinghoff E Simonsick EM Newman AB Satterfield S Rosano C Rubin SM Ayonayon HN Harris TB Predictors of maintaining cognitive function in older adults: the Health ABC studyNeurology2009 7220292035

    Not in our library10.1212/wnl.0b013e3181a92c36

  152. 152.

    Chang M Jonsson PV Snaedal J Bjornsson S Saczynski JS Aspelund T Eiriksdottir G Jonsdottir MK Lopez OL Harris TB Gudnason V Launer LJ The effect of midlife physical activity on cognitive function among older adults: AGES–Reykjavik studyJ Gerontol A Biol Sci Med Sci2010 6513691374

    Not in our library10.1093/gerona/glq152

  153. 153.

    Etgen T Sander D Huntgeburth U Poppert H Forstl H Bickel H Physical activity and incident cognitive impairment in elderly persons: the INVADE studyArch Intern Med2010 170186193

    Not in our library10.1001/archinternmed.2009.498

  154. 154.

    Gillum RF Obisesan TO Physical activity, cognitive function, and mortality in a US national cohortAnn Epidemiol2010 20251257

    Not in our library10.1016/j.annepidem.2010.01.005

  155. 155.

    Middleton LE Barnes DE Lui LY Yaffe K Physical activity over the life course and its association with cognitive performance and impairment in old ageJ Am Geriatr Soc2010 5813221326

    Not in our library10.1111/j.1532-5415.2010.02903.x

  156. 156.

    Buchman AS Boyle PA Yu L Shah RC Wilson RS Bennett DA Total daily physical activity and the risk of AD and cognitive decline in older adultsNeurology2012 7813231329

    Not in our library10.1212/wnl.0b013e3182535d35

  157. 157.

    Lin F Friedman E Quinn J Chen DG Mapstone M Effect of leisure activities on inflammation and cognitive function in an aging sampleArch Gerontol Geriatr2012 54e398404

    Not in our library10.1016/j.archger.2012.02.002

  158. 158.

    Norton MC Dew J Smith H Fauth E Piercy KW Breitner JC Tschanz J Wengreen H Welsh-Bohmer K Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache county studyJ Am Geriatr Soc2012 60405412

    Not in our library10.1111/j.1532-5415.2011.03860.x

  159. 159.

    Jarvis MJ Does caffeine intake enhance absolute levels of cognitive performance?Psychopharmacology (Berl)1993 1104552

    Not in our library10.1007/bf02246949

  160. 160.

    Johnson-Kozlow M Kritz-Silverstein D Barrett-Connor E Morton D Coffee consumption and cognitive function among older adultsAm J Epidemiol2002 156842850

    Not in our library10.1093/aje/kwf119

  161. 161.

    van Boxtel MP Schmitt JA Bosma H Jolles J The effects of habitual caffeine use on cognitive change: a longitudinal perspectivePharmacol Biochem Behav2003 75921927

    Not in our library10.1016/s0091-3057(03)00171-0

  162. 162.

    Kuriyama S Hozawa A Ohmori K Shimazu T Matsui T Ebihara S Awata S Nagatomi R Arai H Tsuji I Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1Am J Clin Nutr2006 83355361

    Not in our library10.1093/ajcn/83.2.355

  163. 163.

    van Gelder BM Buijsse B Tijhuis M Kalmijn S Giampaoli S Nissinen A Kromhout D Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE StudyEur J Clin Nutr2007 61226232

    Not in our library10.1038/sj.ejcn.1602495

  164. 164.

    Ng TP Feng L Niti M Kua EH Yap KB Tea consumption and cognitive impairment and decline in older Chinese adultsAm J Clin Nutr2008 88224231

    Not in our library10.1093/ajcn/88.1.224

  165. 165.

    Eskelinen MH Ngandu T Tuomilehto J Soininen H Kivipelto M Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE studyJ Alzheimers Dis2009 168591

    Not in our library10.3233/jad-2009-0920

  166. 166.

    Laitala VS Kaprio J Koskenvuo M Raiha I Rinne JO Silventoinen K Coffee drinking in middle age is not associated with cognitive performance in old ageAm J Clin Nutr2009 90640646

    Not in our library10.3945/ajcn.2009.27660

  167. 167.

    Nurk E Refsum H Drevon CA Tell GS Nygaard HA Engedal K Smith AD Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performanceJ Nutr2009 139120127

    Not in our library10.3945/jn.108.095182

  168. 168.

    Smith AP Caffeine, cognitive failures and health in a non-working community sampleHum Psychopharmacol2009 242934

    Not in our library10.1002/hup.991

  169. 169.

    Corley J Jia X Kyle JA Gow AJ Brett CE Starr JM McNeill G Deary IJ Caffeine consumption and cognitive function at age 70: the Lothian birth cohort 1936 studyPsychosom Med2010 72206214

    Not in our library10.1097/psy.0b013e3181c92a9c

  170. 170.

    Feng L Gwee X Kua EH Ng TP Cognitive function and tea consumption in community dwelling older Chinese in SingaporeJ Nutr Health Aging2010 14433438

    Not in our library10.1007/s12603-010-0095-9

  171. 171.

    Ritchie K Artero S Portet F Brickman A Muraskin J Beanino E Ancelin ML Carriere I Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidenceJ Alzheimers Dis2010 20Suppl 1S161166

    Not in our library10.3233/jad-2010-1387

  172. 172.

    Santos C Lunet N Azevedo A de Mendonca A Ritchie K Barros H Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from PortugalJ Alzheimers Dis2010 20Suppl 1S175185

    Not in our library10.3233/jad-2010-091303

  173. 173.

    Arab L Biggs ML O'Meara ES Longstreth WT Crane PK Fitzpatrick AL Gender differences in tea, coffee, and cognitive decline in the elderly: the cardiovascular health studyJ Alzheimers Dis2011 27553566

    Not in our library10.3233/jad-2011-110431

  174. 174.

    Gelber RP Petrovitch H Masaki KH Ross GW White LR Coffee intake in midlife and risk of dementia and its neuropathologic correlatesJ Alzheimers Dis2011 23607615

    Not in our library10.3233/jad-2010-101428

  175. 175.

    Feng L Li J Ng TP Lee TS Kua EH Zeng Y Tea drinking and cognitive function in oldest-old chineseJ Nutr Health Aging2012 16754758

    Not in our library10.1007/s12603-012-0077-1

  176. 176.

    Jama JW Launer LJ Witteman JC den Breeijen JH Breteler MM Grobbee DE Hofman A Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam StudyAm J Epidemiol1996 144275280

    Not in our library10.1093/oxfordjournals.aje.a008922

  177. 177.

    Mendelsohn AB Belle SH Stoehr GP Ganguli M Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES project. Monongahela Valley independent elders surveyAm J Epidemiol1998 1483844

    Not in our library10.1093/oxfordjournals.aje.a009556

  178. 178.

    Morris MC Beckett LA Scherr PA Hebert LE Bennett DA Field TS Evans DA Vitamin E and vitamin C supplement use and risk of incident Alzheimer diseaseAlzheimer Dis Assoc Disord1998 12121126

    Not in our library10.1097/00002093-199809000-00001

  179. 179.

    Schmidt R Hayn M Reinhart B Roob G Schmidt H Schumacher M Watzinger N Launer LJ Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian stroke prevention studyJ Am Geriatr Soc1998 4614071410

    Not in our library10.1111/j.1532-5415.1998.tb06008.x

  180. 180.

    Masaki KH Losonczy KG Izmirlian G Foley DJ Ross GW Petrovitch H Havlik R White LR Association of vitamin E and C supplement use with cognitive function and dementia in elderly menNeurology2000 5412651272

    Not in our library10.1212/wnl.54.6.1265

  181. 181.

    Peacock JM Folsom AR Knopman DS Mosley TH Goff DC Jr Szklo M Dietary antioxidant intake and cognitive performance in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study investigatorsPublic Health Nutr2000 3337343

    Not in our library10.1017/s1368980000000380

  182. 182.

    Engelhart MJ Geerlings MI Ruitenberg A van Swieten JC Hofman A Witteman JC Breteler MM Dietary intake of antioxidants and risk of Alzheimer diseaseJAMA2002 28732233229

    Not in our library10.1001/jama.287.24.3223

  183. 183.

    Morris MC Evans DA Bienias JL Tangney CC Bennett DA Aggarwal N Wilson RS Scherr PA Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community studyJAMA2002 28732303237

    Not in our library10.1001/jama.287.24.3230

  184. 184.

    Morris MC Evans DA Bienias JL Tangney CC Wilson RS Vitamin E and cognitive decline in older personsArch Neurol2002 5911251132

    Not in our library10.1001/archneur.59.7.1125

  185. 185.

    Gray SL Hanlon JT Landerman LR Artz M Schmader KE Fillenbaum GG Is antioxidant use protective of cognitive function in the community-dwelling elderly?Am J Geriatr Pharmacother2003 1310

    Not in our library10.1016/s1543-5946(03)80011-9

  186. 186.

    Grodstein F Chen J Willett WC High-dose antioxidant supplements and cognitive function in community-dwelling elderly womenAm J Clin Nutr2003 77975984

    Not in our library10.1093/ajcn/77.4.975

  187. 187.

    Luchsinger JA Tang MX Shea S Mayeux R Antioxidant vitamin intake and risk of Alzheimer diseaseArch Neurol2003 60203208

    Not in our library10.1001/archneur.60.2.203

  188. 188.

    Laurin D Masaki KH Foley DJ White LR Launer LJ Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia aging studyAm J Epidemiol2004 159959967

    Not in our library10.1093/aje/kwh124

  189. 189.

    Zandi PP Anthony JC Khachaturian AS Stone SV Gustafson D Tschanz JT Norton MC Welsh-Bohmer KA Breitner JC Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache county studyArch Neurol2004 618288

    Not in our library10.1001/archneur.61.1.82

  190. 190.

    Cherubini A Martin A Andres-Lacueva C Di Iorio A Lamponi M Mecocci P Bartali B Corsi A Senin U Ferrucci L Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI studyNeurobiol Aging2005 26987994

    Not in our library10.1016/j.neurobiolaging.2004.09.002

  191. 191.

    Engelhart MJ Ruitenberg A Meijer J Kiliaan A van Swieten JC Hofman A Witteman JC Breteler MM Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive declineDement Geriatr Cogn Disord2005 19134139

    Not in our library10.1159/000082884

  192. 192.

    Fillenbaum GG Kuchibhatla MN Hanlon JT Artz MB Pieper CF Schmader KE Dysken MW Gray SL Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin EAnn Pharmacother2005 3920092014

    Not in our library10.1345/aph.1g280

  193. 193.

    Maxwell CJ Hicks MS Hogan DB Basran J Ebly EM Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementiaDement Geriatr Cogn Disord2005 204551

    Not in our library10.1159/000085074

  194. 194.

    Morris MC Evans DA Tangney CC Bienias JL Wilson RS Aggarwal NT Scherr PA Relation of the tocopherol forms to incident Alzheimer disease and to cognitive changeAm J Clin Nutr2005 81508514

    Not in our library10.1093/ajcn.81.2.508

  195. 195.

    Akbaraly NT Faure H Gourlet V Favier A Berr C Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA studyJ Gerontol A Biol Sci Med Sci2007 62308316

    Not in our library10.1093/gerona/62.3.308

  196. 196.

    Dunn JE Weintraub S Stoddard AM Banks S Serum alpha-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairmentNeurology2007 68670676

    Not in our library10.1212/01.wnl.0000255940.13116.86

  197. 197.

    Wengreen HJ Munger RG Corcoran CD Zandi P Hayden KM Fotuhi M Skoog I Norton MC Tschanz J Breitner JC Welsh-Bohmer KA Antioxidant intake and cognitive function of elderly men and women: the Cache county studyJ Nutr Health Aging2007 11230237

    Not in our library

  198. 198.

    Fotuhi M Zandi PP Hayden KM Khachaturian AS Szekely CA Wengreen H Munger RG Norton MC Tschanz JT Lyketsos CG Breitner JC Welsh-Bohmer K Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache county studyAlzheimers Dement2008 4223227

    Not in our library10.1016/j.jalz.2008.01.004

  199. 199.

    Gray SL Anderson ML Crane PK Breitner JC McCormick W Bowen JD Teri L Larson E Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adultsJ Am Geriatr Soc2008 56291295

    Not in our library10.1111/j.1532-5415.2007.01531.x

  200. 200.

    Ravaglia G Forti P Lucicesare A Pisacane N Rietti E Mangialasche F Cecchetti R Patterson C Mecocci P Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohortAm J Clin Nutr2008 8713061313

    Not in our library10.1093/ajcn/87.5.1306

  201. 201.

    Devore EE Kang JH Stampfer MJ Grodstein F Total antioxidant capacity of diet in relation to cognitive function and declineAm J Clin Nutr2010 9211571164

    Not in our library10.3945/ajcn.2010.29634

  202. 202.

    McNeill G Jia X Whalley LJ Fox HC Corley J Gow AJ Brett CE Starr JM Deary IJ Antioxidant and B vitamin intake in relation to cognitive function in later life in the Lothian birth cohort 1936Eur J Clin Nutr2011 65619626

    Not in our library10.1038/ejcn.2011.2

  203. 203.

    Kalmijn S Launer LJ Lindemans J Bots ML Hofman A Breteler MM Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam studyAm J Epidemiol1999 150283289

    Not in our library10.1093/oxfordjournals.aje.a010000

  204. 204.

    Duthie SJ Whalley LJ Collins AR Leaper S Berger K Deary IJ Homocysteine, B vitamin status, and cognitive function in the elderlyAm J Clin Nutr2002 75908913

    Not in our library10.1093/ajcn/75.5.908

  205. 205.

    Prins ND Den Heijer T Hofman A Koudstaal PJ Jolles J Clarke R Breteler MM Homocysteine and cognitive function in the elderly: the Rotterdam scan studyNeurology2002 5913751380

    Not in our library10.1212/01.wnl.0000032494.05619.93

  206. 206.

    Seshadri S Beiser A Selhub J Jacques PF Rosenberg IH D'Agostino RB Wilson PW Wolf PA Plasma homocysteine as a risk factor for dementia and Alzheimer's diseaseN Engl J Med2002 346476483

    Not in our library10.1056/nejmoa011613

  207. 207.

    Miller JW Green R Ramos MI Allen LH Mungas DM Jagust WJ Haan MN Homocysteine and cognitive function in the Sacramento area Latino study on agingAm J Clin Nutr2003 78441447

    Not in our library10.1093/ajcn/78.3.441

  208. 208.

    Ravaglia G Forti P Maioli F Muscari A Sacchetti L Arnone G Nativio V Talerico T Mariani E Homocysteine and cognitive function in healthy elderly community dwellers in ItalyAm J Clin Nutr2003 77668673

    Not in our library10.1093/ajcn/77.3.668

  209. 209.

    Luchsinger JA Tang MX Shea S Miller J Green R Mayeux R Plasma homocysteine levels and risk of Alzheimer diseaseNeurology2004 6219721976

    Not in our library10.1212/01.wnl.0000129504.60409.88

  210. 210.

    Ariogul S Cankurtaran M Dagli N Khalil M Yavuz B Vitamin B12, folate, homocysteine and dementia: are they really related?Arch Gerontol Geriatr2005 40139146

    Not in our library10.1016/j.archger.2004.07.005

  211. 211.

    Campbell AK Jagust WJ Mungas DM Miller JW Green R Haan MN Allen LH Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine, is associated with dementia in elderly LatinosJ Nutr Health Aging2005 93943

    Not in our library

  212. 212.

    Elias MF Sullivan LM D'Agostino RB Elias PK Jacques PF Selhub J Seshadri S Au R Beiser A Wolf PA Homocysteine and cognitive performance in the Framingham offspring study: age is importantAm J Epidemiol2005 162644653

    Not in our library10.1093/aje/kwi259

  213. 213.

    Kado DM Karlamangla AS Huang MH Troen A Rowe JW Selhub J Seeman TE Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful agingAm J Med2005 118161167

    Not in our library10.1016/j.amjmed.2004.08.019

  214. 214.

    Mooijaart SP Gussekloo J Frolich M Jolles J Stott DJ Westendorp RG de Craen AJ Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus studyAm J Clin Nutr2005 82866871

    Not in our library10.1093/ajcn/82.4.866

  215. 215.

    Quadri P Fragiacomo C Pezzati R Zanda E Tettamanti M Lucca U Homocysteine and B vitamins in mild cognitive impairment and dementiaClin Chem Lab Med2005 4310961100

    Not in our library10.1515/cclm.2005.191

  216. 216.

    Ramos MI Allen LH Mungas DM Jagust WJ Haan MN Green R Miller JW Low folate status is associated with impaired cognitive function and dementia in the Sacramento area Latino study on agingAm J Clin Nutr2005 8213461352

    Not in our library10.1093/ajcn/82.6.1346

  217. 217.

    Ravaglia G Forti P Maioli F Martelli M Servadei L Brunetti N Porcellini E Licastro F Homocysteine and folate as risk factors for dementia and Alzheimer diseaseAm J Clin Nutr2005 82636643

    Not in our library10.1093/ajcn.82.3.636

  218. 218.

    Schafer JH Glass TA Bolla KI Mintz M Jedlicka AE Schwartz BS Homocysteine and cognitive function in a population-based study of older adultsJ Am Geriatr Soc2005 53381388

    Not in our library10.1111/j.1532-5415.2005.53153.x

  219. 219.

    Tucker KL Qiao N Scott T Rosenberg I Spiro A 3rd High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans affairs normative aging studyAm J Clin Nutr2005 82627635

    Not in our library10.1093/ajcn.82.3.627

  220. 220.

    Elias MF Robbins MA Budge MM Elias PK Brennan SL Johnston C Nagy Z Bates CJ Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: the Maine-Syracuse studyPsychosom Med2006 68547554

    Not in our library10.1097/01.psy.0000221380.92521.51

  221. 221.

    Feng L Ng TP Chuah L Niti M Kua EH Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore longitudinal ageing studyAm J Clin Nutr2006 8415061512

    Not in our library10.1093/ajcn/84.6.1506

  222. 222.

    van Raamt AF Kalmijn S Mali WP van Zandvoort MJ van der Graaf Y Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial disease studyJ Am Geriatr Soc2006 54575579

    Not in our library10.1111/j.1532-5415.2006.00653.x

  223. 223.

    Clarke R Birks J Nexo E Ueland PM Schneede J Scott J Molloy A Evans JG Low vitamin B-12 status and risk of cognitive decline in older adultsAm J Clin Nutr2007 8613841391

    Not in our library10.1093/ajcn/86.5.1384

  224. 224.

    Haan MN Miller JW Aiello AE Whitmer RA Jagust WJ Mungas DM Allen LH Green R Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento area Latino study on agingAm J Clin Nutr2007 85511517

    Not in our library10.1093/ajcn/85.2.511

  225. 225.

    Kim J Park MH Kim E Han C Jo SA Jo I Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean populationJ Nutr2007 13720932097

    Not in our library10.1093/jn/137.9.2093

  226. 226.

    Elias MF Robbins MA Budge MM Elias PK Dore GA Brennan SL Johnston C Nagy Z Homocysteine and cognitive performance: modification by the ApoE genotypeNeurosci Lett2008 4306469

    Not in our library10.1016/j.neulet.2007.10.021

  227. 227.

    Kim JM Kim SW Shin IS Yang SJ Park WY Kim SJ Shin HY Yoon JS Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderlyPsychiatry Investig2008 53640

    Not in our library10.4306/pi.2008.5.1.36

  228. 228.

    Kim JM Stewart R Kim SW Shin IS Yang SJ Shin HY Yoon JS Changes in folate, vitamin B12 and homocysteine associated with incident dementiaJ Neurol Neurosurg Psychiatry2008 79864868

    Not in our library10.1136/jnnp.2007.131482

  229. 229.

    Reitz C Tang MX Miller J Green R Luchsinger JA Plasma homocysteine and risk of mild cognitive impairmentDement Geriatr Cogn Disord2009 271117

    Not in our library10.1159/000182421

  230. 230.

    Redeen S Ryberg A Petersson F Eriksson O Nagga K Borch K Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementiaDig Dis Sci2010 55351358

    Not in our library10.1007/s10620-009-0761-0

  231. 231.

    van den Kommer TN Dik MG Comijs HC Jonker C Deeg DJ Homocysteine and inflammation: predictors of cognitive decline in older persons?Neurobiol Aging2010 3117001709

    Not in our library10.1016/j.neurobiolaging.2008.09.009

  232. 232.

    Perneczky R Alexopoulos P Kurz A Bickel H Cognitive reserve, homocysteine, and cognition in the Bavarian school sisters studyJ Am Geriatr Soc2011 5917541756

    Not in our library10.1111/j.1532-5415.2011.03568.x

  233. 233.

    Zylberstein DE Lissner L Bjorkelund C Mehlig K Thelle DS Gustafson D Ostling S Waern M Guo X Skoog I Midlife homocysteine and late-life dementia in women. A prospective population studyNeurobiol Aging2011 32380386

    Not in our library10.1016/j.neurobiolaging.2009.02.024

  234. 234.

    Ford AH Flicker L Alfonso H Hankey GJ Norman PE van Bockxmeer FM Almeida OP Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementiaJ Neurol Neurosurg Psychiatry2012 837075

    Not in our library10.1136/jnnp.2011.242446

  235. 235.

    Ford AH Flicker L Hankey GJ Norman P van Bockxmeer FM Almeida OP Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men studyMol Psychiatry2012 17559566

    Not in our library10.1038/mp.2011.18

  236. 236.

    Kalmijn S Feskens EJ Launer LJ Kromhout D Polyunsaturated fatty acids, antioxidants, and cognitive function in very old menAm J Epidemiol1997 1453341

    Not in our library10.1093/oxfordjournals.aje.a009029

  237. 237.

    Kalmijn S Launer LJ Ott A Witteman JC Hofman A Breteler MM Dietary fat intake and the risk of incident dementia in the Rotterdam studyAnn Neurol1997 42776782

    Not in our library10.1002/ana.410420514

  238. 238.

    Engelhart MJ Geerlings MI Ruitenberg A Van Swieten JC Hofman A Witteman JC Breteler MM Diet and risk of dementia: does fat matter?: the Rotterdam studyNeurology2002 5919151921

    Not in our library10.1212/01.wnl.0000038345.77753.46

  239. 239.

    Morris MC Evans DA Bienias JL Tangney CC Bennett DA Wilson RS Aggarwal N Schneider J Consumption of fish and n-3 fatty acids and risk of incident Alzheimer diseaseArch Neurol2003 60940946

    Not in our library10.1001/archneur.60.7.940

  240. 240.

    Kalmijn S van Boxtel MP Ocke M Verschuren WM Kromhout D Launer LJ Dietary intake of fatty acids and fish in relation to cognitive performance at middle ageNeurology2004 62275280

    Not in our library10.1212/01.wnl.0000103860.75218.a5

  241. 241.

    Morris MC Evans DA Tangney CC Bienias JL Wilson RS Fish consumption and cognitive decline with age in a large community studyArch Neurol2005 6212184953

    Not in our library10.1001/archneur.62.12.noc50161

  242. 242.

    Barberger-Gateau P Raffaitin C Letenneur L Berr C Tzourio C Dartigues JF Alperovitch A Dietary patterns and risk of dementia: the Three-City cohort studyNeurology2007 6919211930

    Not in our library10.1212/01.wnl.0000278116.37320.52

  243. 243.

    Beydoun MA Kaufman JS Satia JA Rosamond W Folsom AR Plasma n-3 fatty acids and risk of cognitive decline among older adults: the atherosclerosis risk in communities (ARIC) studyAm J Clin Nutr2007 844110311In press

    Not in our library10.1093/ajcn/85.4.1103

  244. 244.

    Cherubini A Andres-Lacueva C Martin A Lauretani F Iorio AD Bartali B Corsi A Bandinelli S Mattson MP Ferrucci L Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI studyJ Gerontol A Biol Sci Med Sci2007 6211201126

    Not in our library10.1093/gerona/62.10.1120

  245. 245.

    Dullemeijer C Durga J Brouwer IA van de Rest O Kok FJ Brummer RJ van Boxtel MP Verhoef P n 3 fatty acid proportions in plasma and cognitive performance in older adultsAm J Clin Nutr2007 8614791485

    Not in our library10.1093/ajcn/86.5.1479

  246. 246.

    Beydoun MA Kaufman JS Sloane PD Heiss G Ibrahim J n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the atherosclerosis risk in communities (ARIC) studyPublic Health Nutr2008 111729

    Not in our library10.1017/s1368980007000080

  247. 247.

    Eskelinen MH Ngandu T Helkala EL Tuomilehto J Nissinen A Soininen H Kivipelto M Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE studyInt J Geriatr Psychiatry2008 23741747

    Not in our library10.1002/gps.1969

  248. 248.

    Samieri C Feart C Letenneur L Dartigues JF Peres K Auriacombe S Peuchant E Delcourt C Barberger-Gateau P Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia riskAm J Clin Nutr2008 88714721

    Not in our library10.1093/ajcn/88.3.714

  249. 249.

    Albanese E Dangour AD Uauy R Acosta D Guerra M Guerra SS Huang Y Jacob KS de Rodriguez JL Noriega LH Salas A Sosa AL Sousa RM Williams J Ferri CP Prince MJ Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 dementia research group population-based studyAm J Clin Nutr2009 90392400

    Not in our library10.3945/ajcn.2009.27580

  250. 250.

    Devore EE Grodstein F van Rooij FJ Hofman A Rosner B Stampfer MJ Witteman JC Breteler MM Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia riskAm J Clin Nutr2009 90170176

    Not in our library10.3945/ajcn.2008.27037

  251. 251.

    Kroger E Verreault R Carmichael PH Lindsay J Julien P Dewailly E Ayotte P Laurin D Omega-3 fatty acids and risk of dementia: the Canadian study of health and agingAm J Clin Nutr2009 90184192

    Not in our library10.3945/ajcn.2008.26987

  252. 252.

    van de Rest O Spiro A 3rd Krall-Kaye E Geleijnse JM de Groot LC Tucker KL Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans affairs normative aging studyJ Nutr2009 13923292336

    Not in our library10.3945/jn.109.113647

  253. 253.

    Vercambre MN Boutron-Ruault MC Ritchie K Clavel-Chapelon F Berr C Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French womenBr J Nutr2009 102419427

    Not in our library10.1017/s0007114508201959

  254. 254.

    Gonzalez S Huerta JM Fernandez S Patterson AM Lasheras C The relationship between dietary lipids and cognitive performance in an elderly populationInt J Food Sci Nutr2010 61217225

    Not in our library10.3109/09637480903348098

  255. 255.

    Muldoon MF Ryan CM Sheu L Yao JK Conklin SM Manuck SB Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthoodJ Nutr2010 140848853

    Not in our library10.3945/jn.109.119578

  256. 256.

    Gao Q Niti M Feng L Yap KB Ng TP Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore longitudinal aging studiesJ Nutr Health Aging2011 153235

    Not in our library10.1007/s12603-011-0010-z

  257. 257.

    Kesse-Guyot E Peneau S Ferry M Jeandel C Hercberg S Galan P Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive functionJ Nutr Health Aging2011 15115120

    Not in our library10.1007/s12603-011-0023-7

  258. 258.

    Samieri C Feart C Proust-Lima C Peuchant E Dartigues JF Amieva H Barberger-Gateau P omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depressionNeurobiol Aging2011 322317e2313-2322

    Not in our library10.1016/j.neurobiolaging.2010.03.020

  259. 259.

    Thomson TM Endnote X32010 Philadelphia, PA: Thomson Reuters

    Not in our library

  260. 260.

    Petitti DB Petitti DBStatistical methods in meat-analysisMeta-analysis. Decision Analysis, and cost-effectiveness analysis2000 2000New York, NY: Oxford University Press

    Not in our library

  261. 261.

    Hildebrandt M Bender R Gehrmann U Blettner M Calculating confidence intervals for impact numbersBMC Med Res Methodol2006 632

    Not in our library10.1186/1471-2288-6-32

  262. 262.

    Egger M Smith GD Altman DG Systematic Reviews in heatlh care: Meta-analysis in context2001 2London. UK: the BMJ Publishing Group

    Not in our library

  263. 263.

    Egger M Smith GD Schneider M Minder C Bias in meta-analysis detected by a simple, graphical testBMJ1997 315629634

    Not in our library10.1136/bmj.315.7109.629

  264. 264.

    Begg CB Mazumdar M Operating characteristics of a rank correlation test for publication biasBiometrics1994 5010881101

    Not in our library

  265. 265.

    Egger M Davey Smith G Schneider M Minder C Davey Smith G Schneider M Minder C Bias in meta-analysis detected by a simple, graphical testBMJ1997 315629634

    Not in our library10.1136/bmj.315.7109.629

  266. 266.

    STATAEditor edStatistics/Data Analysis: Release 11.0Book Statistics/Data Analysis: Release 11.02009 City: Stata Corporation

    Not in our library

  267. 267.

    Albert MS How does education affect cognitive function?Ann Epidemiol1995 57678

    Not in our library10.1016/1047-2797(94)00044-t

  268. 268.

    Wilson RS Bennett DA Beckett LA Morris MC Gilley DW Bienias JL Scherr PA Evans DA Cognitive activity in older persons from a geographically defined populationJ Gerontol B Psychol Sci Soc Sci1999 54P155160

    Not in our library10.1093/geronb/54b.3.p155

  269. 269.

    Gorelick PB Sacco RL Smith DB Alberts M Mustone-Alexander L Rader D Ross JL Raps E Ozer MN Brass LM Malone ME Goldberg S Booss J Hanley DF Toole JF Greengold NL Rhew DC Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke AssociationJAMA1999 28111121120

    Not in our library10.1001/jama.281.12.1112

  270. 270.

    Markesbery WR Carney JM Oxidative alterations in Alzheimer's diseaseBrain Pathol1999 9133146

    Not in our library10.1111/j.1750-3639.1999.tb00215.x

  271. 271.

    Kellar KJ, Wonnacott SNicotinic cholinergic receptors in Alzheimer's disease, in nicotine psychopharmacology: molecular, cellular, and behavioral aspects1990 Oxford: Oxford University Press

    Not in our library

  272. 272.

    Nordberg A Biological markers and the cholinergic hypothesis in Alzheimer's diseaseActa Neurol Scand Suppl1992 1395458

    Not in our library10.1111/j.1600-0404.1992.tb04455.x

  273. 273.

    Letenneur L Larrieu S Barberger-Gateau P Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studiesBiomed Pharmacother2004 589599

    Not in our library10.1016/j.biopha.2003.12.004

  274. 274.

    Rogers RL Meyer JS Mortel KF After reaching retirement age physical activity sustains cerebral perfusion and cognitionJ Am Geriatr Soc1990 38123128

    Not in our library10.1111/j.1532-5415.1990.tb03472.x

  275. 275.

    Dustman RE Ruhling RO Russell EM Shearer DE Bonekat HW Shigeoka JW Wood JS Bradford DC Aerobic exercise training and improved neuropsychological function of older individualsNeurobiol Aging1984 53542

    Not in our library10.1016/0197-4580(84)90083-6

  276. 276.

    Spirduso WW Physical fitness, aging, and psychomotor speed: a reviewJ Gerontol1980 35850865

    Not in our library10.1093/geronj/35.6.850

  277. 277.

    Gomez-Pinilla F Dao L So V Physical exercise induces FGF-2 and its mRNA in the hippocampusBrain Res1997 76418

    Not in our library10.1016/s0006-8993(97)00375-2

  278. 278.

    Cotman CW Engesser-Cesar C Exercise enhances and protects brain functionExerc Sport Sci Rev2002 307579

    Not in our library10.1097/00003677-200204000-00006

  279. 279.

    Pignatti F Rozzini R Trabucchi M Physical activity and cognitive decline in elderly personsArch Intern Med2002 162361362

    Not in our library10.1001/archinte.162.3.361

  280. 280.

    James JE Caffeine & health1991 London, England: Academic

    Not in our library

  281. 281.

    Battig K Buzzi R Effect of coffee on the speed of subject-paced information processingNeuropsychobiology1986 16126130

    Not in our library10.1159/000118312

  282. 282.

    Riedel W Hogervorst E Leboux R Verhey F van Praag H Jolles J Caffeine attenuates scopolamine-induced memory impairment in humansPsychopharmacology (Berl)1995 122158168

    Not in our library10.1007/bf02246090

  283. 283.

    Behl C Amyloid beta-protein toxicity and oxidative stress in Alzheimer's diseaseCell Tissue Res1997 290471480

    Not in our library10.1007/s004410050955

  284. 284.

    Christen Y Oxidative stress and Alzheimer diseaseAm J Clin Nutr2000 71621S629S

    Not in our library10.1093/ajcn/71.2.621s

  285. 285.

    Grundman M Vitamin E and Alzheimer disease: the basis for additional clinical trialsAm J Clin Nutr2000 71630S636S

    Not in our library10.1093/ajcn/71.2.630s

  286. 286.

    Refsum H Ueland PM Nygard O Vollset SE Homocysteine and cardiovascular diseaseAnnu Rev Med1998 493162

    Not in our library10.1146/annurev.med.49.1.31

  287. 287.

    Garcia A Haron Y Pulman K Hua L Freedman M Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up studyJ Gerontol A Biol Sci Med Sci2004 5913231327

    Not in our library10.1093/gerona/59.12.1323

  288. 288.

    Teunissen CE Blom AH Van Boxtel MP Bosma H de Bruijn C Jolles J Wauters BA Steinbusch HW de Vente J Homocysteine: a marker for cognitive performance? A longitudinal follow-up studyJ Nutr Health Aging2003 7153159

    Not in our library

  289. 289.

    Scott TM Tucker KL Bhadelia A Benjamin B Patz S Bhadelia R Liebson E Price LL Griffith J Rosenberg I Folstein MF Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disordersAm J Geriatr Psychiatry2004 12631638

    Not in our library10.1176/appi.ajgp.12.6.631

  290. 290.

    Dufouil C Alperovitch A Ducros V Tzourio C Homocysteine, white matter hyperintensities, and cognition in healthy elderly peopleAnn Neurol2003 53214221

    Not in our library10.1002/ana.10440

  291. 291.

    Sachdev PS Valenzuela M Wang XL Looi JC Brodaty H Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individualsNeurology2002 5815391541

    Not in our library10.1212/wnl.58.10.1539

  292. 292.

    Bleich S Kornhuber J Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individualsNeurology2003 601220author reply 1220

    Not in our library10.1212/wnl.60.7.1220

  293. 293.

    den Heijer T Vermeer SE Clarke R Oudkerk M Koudstaal PJ Hofman A Breteler MM Homocysteine and brain atrophy on MRI of non-demented elderlyBrain2003 126170175

    Not in our library10.1093/brain/awg006

  294. 294.

    Bottiglieri T Homocysteine and folate metabolism in depressionProg Neuropsychopharmacol Biol Psychiatry2005 2911031112

    Not in our library10.1016/j.pnpbp.2005.06.021

  295. 295.

    Selhub J Jacques PF Wilson PW Rush D Rosenberg IH Vitamin status and intake as primary determinants of homocysteinemia in an elderly populationJAMA1993 27026932698

    Not in our library10.1001/jama.1993.03510220049033

  296. 296.

    Li L Cao D Desmond R Rahman A Lah JJ Levey AI Zamrini E Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer diseaseDement Geriatr Cogn Disord2008 26384390

    Not in our library10.1159/000164271

  297. 297.

    Vidal JS Dufouil C Ducros V Tzourio C Homocysteine, folate and cognition in a large community-based sample of elderly people–the 3C Dijon StudyNeuroepidemiology2008 30207214

    Not in our library10.1159/000126914

  298. 298.

    Kruman II Culmsee C Chan SL Kruman Y Guo Z Penix L Mattson MP Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicityJ Neurosci2000 2069206926

    Not in our library10.1523/jneurosci.20-18-06920.2000

  299. 299.

    Parsons RB Waring RH Ramsden DB Williams AC In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell linesNeurotoxicology1998 19599603

    Not in our library

  300. 300.

    Arab L Biomarkers of fat and fatty acid intakeJ Nutr2003 133Suppl 3925S932S

    Not in our library10.1093/jn/133.3.925s

  301. 301.

    Andreassi M Forleo P Di Lorio A Masci S Abate G Amerio P Efficacy of gamma-linolenic acid in the treatment of patients with atopic dermatitisJ Int Med Res1997 25266274

    Not in our library10.1177/030006059702500504

  302. 302.

    Cerolini S Kelso KA Noble RC Speake BK Pizzi F Cavalchini LG Relationship between spermatozoan lipid composition and fertility during aging of chickensBiol Reprod1997 57976980

    Not in our library10.1095/biolreprod57.5.976

  303. 303.

    Zhang L The effects of essential fatty acids preparation in the treatment of intrauterine growth retardationAm J Perinatol1997 14535537

    Not in our library10.1055/s-2007-994329

  304. 304.

    Bjerve KS Omega 3 fatty acid deficiency in man: implications for the requirement of alpha-linolenic acid and long-chain omega 3 fatty acidsWorld Rev Nutr Diet1991 66133142

    Not in our library10.1159/000419285

  305. 305.

    Wainwright PE Dietary essential fatty acids and brain function: a developmental perspective on mechanismsProc Nutr Soc2002 616169

    Not in our library10.1079/pns2001130

  306. 306.

    Haag M Essential fatty acids and the brainCan J Psychiatry2003 48195203

    Not in our library10.1177/070674370304800308

  307. 307.

    de Wilde MC Hogyes E Kiliaan AJ Farkas T Luiten PG Farkas E Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive ratsBrain Res2003 988919

    Not in our library10.1016/s0006-8993(03)03320-1

Cited by papers we hold 16

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.